Product Name,Active Ingredient,Application Type,Product Registrant,Date of Approval,Registration No.
ABRYSVO POWDER AND SOLVENT FOR SOLUTION FOR INJECTION,"(Powder) RSV subgroup A stabilized prefusion F protein(0.06 mg/vial),(Powder) RSV subgroup B stabilized prefusion F protein(0.06 mg/vial)",NDA-1: New biological entity,PFIZER PRIVATE LIMITED,23/07/2024,SIN17049P
COMIRNATY ORIGINAL/OMICRON BA.4-5 CONCENTRATE FOR DISPERSION FOR INJECTION 1.5/1.5 MICROGRAMS/DOSE,"Famtozinameran(1.5 ?g/dose),Tozinameran(1.5 ?g/dose)","NDA-2: New dosage form, strength, combination",BIONTECH PHARMACEUTICALS ASIA PACIFIC PTE. LTD.,25/07/2024,SIN17053P
EYLEA SOLUTION FOR INJECTION 114.3 MG/ML,Aflibercept(114.3mg/ml),"NDA-2: New strength, dosing regimen",BAYER (SOUTH EAST ASIA) PTE LTD,05/07/2024,SIN17040P
LITFULO CAPSULE 50MG,Ritlecitinib Tosylate equivalent to Ritlecitinib(50mg),NDA-1: New chemical entity,PFIZER PRIVATE LIMITED,05/07/2024,SIN17041P
"MEGAPTH-G SOLUTION FOR INJECTION 20 MCG/80MCL CARTRIDGE PACK,MEGAPTH-G SOLUTION FOR INJECTION 20 MCG/80MCL PEN + CARTRIDGE PACK",Teriparatide(20 mcg/80 mcl),NDA-2: biosimilar,GOLDPLUS UNIVERSAL PTE LTD,24/07/2024,"SIN17051P,SIN17052P"
"PEMAZYRE TABLETS 13.5 MG,PEMAZYRE TABLETS 9 MG,PEMAZYRE TABLETS 4.5 MG","Pemigatinib(13.50 mg),Pemigatinib(9.00 mg),Pemigatinib(4.50 mg)",NDA-1: New chemical entityNDA-3: New strength,SPECIALISED THERAPEUTICS ASIA PTE LTD,09/07/2024,"SIN17044P,SIN17043P,SIN17042P"
MEKINIST® POWDER FOR ORAL SOLUTION 4.7 MG,Trametinib dimethylsulfoxide 5.30 mg eqv trametinib(4.7 mg),NDA-2: New presentation,NOVARTIS (SINGAPORE) PTE LTD,03/06/2024,SIN17018P
TAFINLAR DISPERSIBLE TABLET 10MG,Dabrafenib mesylate eqv Dabrafenib(10mg),NDA-2: New presentation,NOVARTIS (SINGAPORE) PTE LTD,03/06/2024,SIN17019P
TECENTRIQ SOLUTION FOR INJECTION 1875MG/15ML,Atezolizumab(1875 mg/15ml),NDA-2: New formulation,ROCHE SINGAPORE PTE. LTD.,27/06/2024,SIN17033P
ULTOMIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ML,Ravulizumab(100 mg/mL),NDA-1: New biologcal entity,ASTRAZENECA SINGAPORE PTE LTD,19/06/2024,SIN17026P
"XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED PEN 75MG/0.5ML,XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED PEN 150MG/1.0ML,XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED PEN 300MG/2.0ML","Omalizumab(75.00 mg/0.5 mL),Omalizumab(150.00 mg/1.0 mL),Omalizumab(300.00 mg / 2.0 mL)",NDA-2: New presentationNDA-3: New strengths,NOVARTIS (SINGAPORE) PTE LTD,21/06/2024,"SIN17030P,SIN17031P,SIN17032P"
XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2.0ML,Omalizumab(300.00 mg/2.0 mL),NDA-3: New strength,NOVARTIS (SINGAPORE) PTE LTD,21/06/2024,SIN17029P
AREXVY POWDER AND SUSPENSION FOR SUSPENSION FOR INJECTION 120MCG/0.5ML,RSVPreF3 antigen(120mcg/0.5mL),NDA-1: New biological entity,GLAXOSMITHKLINE PTE LTD,10/05/2024,SIN17008P
BESREMI SOLUTION FOR INJECTION IN PREFILLED SYRINGE 500 MICROGRAMS/ML,Ropeginterferon alfa-2b(500 µg/mL),NDA-1: New biological entity,PHARMAESSENTIA SINGAPORE PTE. LTD,29/05/2024,SIN17014P
"COMIRNATY, DISPERSION FOR INJECTION, 10 MICROGRAMS/DOSE (SINGLE-DOSE VIAL),COMIRNATY, DISPERSION FOR INJECTION, 30 MICROGRAMS/DOSE (SINGLE-DOSE VIAL)","Raxtozinameran(10 ?g/dose),Raxtozinameran(30 mcg/dose)",NDA-2: New presentation,BIONTECH PHARMACEUTICALS ASIA PACIFIC PTE. LTD.,31/05/2024,"SIN17017P,SIN17016P"
"INHIXA SOLUTION FOR INJECTION 6000 ANTI-XA IU (60MG)/0.6ML,INHIXA SOLUTION FOR INJECTION 4000 ANTI-XA IU (40MG)/0.4ML,INHIXA SOLUTION FOR INJECTION 2000 ANTI-XA IU (20MG)/0.2ML","Enoxaparin Sodium(6000 IU (60 MG)/0.6 ML),Enoxaparin Sodium(4000 IU (40 MG)/0.4 ML),Enoxaparin Sodium(2000 IU (20 MG)/0.2 ML)",NDA-3: New strength,PHARMAZEN MEDICALS PTE LTD,07/05/2024,"SIN16997P,SIN16998P,SIN16999P"
"LUNSUMIO CONCENTRATE FOR SOLUTION FOR INFUSION 1MG/ML,LUNSUMIO CONCENTRATE FOR SOLUTION FOR INFUSION 30MG/30ML","Mosunetuzumab(1 mg/ml),Mosunetuzumab(30 mg/30 ml)",NDA-1: New biological entityNDA-3: new strengths,ROCHE SINGAPORE PTE. LTD.,08/05/2024,"SIN17001P,SIN17002P"
VELSIPITY FILM-COATED TABLET 2 MG,Etrasimod L-arginine eqv Etrasimod(2 mg),NDA-1: New chemical entity,PFIZER PRIVATE LIMITED,30/05/2024,SIN17015P
"IMOVAX D.T., SUSPENSION FOR INJECTION IN 0.5 ML PRE-FILLED SYRINGE","Purified Diphtheria Toxoid(? 2 IU/ 0.5 mL),Purified Tetanus Toxoid(? 20   IU/ 0.5mL)",NDA-2: New strength/combination,SANOFI-AVENTIS SINGAPORE PTE. LTD.,30/04/2024,SIN16995P
LEDAGA TOPICAL GEL 160 ?G /G,Chlormethine hydrochloride equivalent to Chlormethine(160 ?g /g ),NDA-1: New chemical entity,JUNIPER BIOLOGICS PTE LTD,15/04/2024,SIN16986P
NEXVIAZYME POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL,AVALGLUCOSIDASE ALFA(100mg/vial),NDA-1: New chemical entity,SANOFI-AVENTIS SINGAPORE PTE. LTD.,24/04/2024,SIN16989P
"TANSTRIVE HARD CAPSULES 40MG,TANSTRIVE HARD CAPSULES 80MG","Selpercatinib(40.0mg),Selpercatinib(80.0mg)",NDA-1: New chemical entityNDA-3: New strength,DKSH SINGAPORE PTE. LTD.,24/04/2024,"SIN16990P,SIN16991P"
COLUMVI CONCENTRATE FOR SOLUTION FOR INFUSION 1MG/ML,Glofitamab(1 mg/ml),NDA-1: New biological entity,ROCHE SINGAPORE PTE. LTD.,05/03/2024,SIN16968P
"JYSELECA FILM-COATED TABLET 100MG,JYSELECA FILM-COATED TABLET 200MG","Filgotinib maleate eqv filgotinib(100 mg),Filgotinib maleate eqv filgotinib(200 mg)",NDA-1: New chemical entityNDA-3: New strength,EISAI (SINGAPORE) PTE. LTD.,27/03/2024,"SIN16980P,SIN16981P"
NEFEGAN MODIFIED RELEASE CAPSULE 4MG,Budesonide(4.00 mg),NDA-2: New formulation,EVEREST MEDICINES (SINGAPORE) PTE. LTD.,19/03/2024,SIN16972P
SKIIP NICOTINE MINI LOZENGE 4 MG (MINT),Nicotine Polacrilex eqv to Nicotine(4.00 mg),NDA-3: New strength,RUBICON RESEARCH PRIVATE LIMITED,13/03/2024,SIN16971P
EYBELIS-S OPHTHALMIC SOLUTION 0.002%W/V,Omidenepag isopropyl(0.02 mg/mL),NDA-2: New formulation,SANTEN PHARMACEUTICAL ASIA PTE. LTD.,19/02/2024,SIN16951P
SIDAPVIA FIXED DOSE COMBINATION TABLET 10 MG/100 MG,"Dapagliflozin propanediol monohydrate eqv Dapagliflozin(10mg), Sitagliptin phosphate monohydrate eqv Sitagliptin(100mg)",NDA-2: New dosage form,ASTRAZENECA SINGAPORE PTE LTD,20/02/2024,SIN16958P
SOTYKTU FILM-COATED TABLETS 6 MG,Deucravacitinib(6.00 mg),NDA-1: New chemical entity,BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.,04/02/2024,SIN16939P
"TECVAYLI SOLUTION FOR INJECTION 10MG/ML,TECVAYLI SOLUTION FOR INJECTION 90MG/ML","Teclistamab(10mg/mL),Teclistamab(90mg/mL)",NDA-1: New biological entityNDA-3: New strength,JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD,16/02/2024,"SIN16948P,SIN16949P"
VAXNEUVANCE® SUSPENSION FOR INJECTION,"(MBC) Pneumococcal Polysaccharide Serotype 1 conjugated to CRM197(2?g),(MBC) Pneumococcal Polysaccharide Serotype 14 conjugated to CRM197(2?g),(MBC) Pneumococcal Polysaccharide Serotype 18C conjugated to CRM197(2?g),(MBC) Pneumococcal Polysaccharide Serotype 19A conjugated to CRM197(2?g),(MBC) Pneumococcal Polysaccharide Serotype 19F conjugated to CRM197(2?g),(MBC) Pneumococcal Polysaccharide Serotype 22F conjugated to CRM197(2?g),(MBC) Pneumococcal Polysaccharide Serotype 23F conjugated to CRM197(2?g),(MBC) Pneumococcal Polysaccharide Serotype 3 conjugated to CRM197(2?g),(MBC) Pneumococcal Polysaccharide Serotype 33F conjugated to CRM197(2?g),(MBC) Pneumococcal Polysaccharide Serotype 4 conjugated to CRM197(2?g),(MBC) Pneumococcal Polysaccharide Serotype 5 conjugated to CRM197(2?g),(MBC) Pneumococcal Polysaccharide Serotype 6A conjugated to CRM197(2?g),(MBC) Pneumococcal Polysaccharide Serotype 6B conjugated to CRM197(4?g),(MBC) Pneumococcal Polysaccharide Serotype 7F conjugated to CRM197(2?g),(MBC) Pneumococcal Polysaccharide Serotype 9V conjugated to CRM197(2?g)",NDA-1: New biological entity,MSD PHARMA (SINGAPORE) PTE. LTD.,07/02/2024,SIN16944P
GENCEBOK SOLUTION FOR INFUSION 10MG/ML,Caffeine Citrate(10.00mg/ml),NDA-2,AXXESSBIO PTE. LTD.,16/01/2024,SIN16929P
LUMIGAN PF (BIMATOPROST OPHTHALMIC SOLUTION) 0.03%,Bimatoprost(0.3 mg/mL),NDA-2,ABBVIE PTE. LTD.,30/01/2024,SIN16938P
COMIRNATY ORIGINAL/OMICRON BA.4-5 CONCENTRATE FOR DISPERSION FOR INJECTION 5/5 MICROGRAMS/DOSE (MDV),"Famtozinameran(5 ?g/dose),Tozinameran(5 ?g/dose)",NDA-2: New combination,BIONTECH PHARMACEUTICALS ASIA PACIFIC PTE. LTD.,18/12/2023,SIN16915P
"LIPOCOMB HARD CAPSULE 20MG/10MG,LIPOCOMB HARD CAPSULE 10MG/10MG","EZETIMIBE (10.00mg), ROSUVASTATIN ZINC EQV ROSUVASTATIN (20.00mg),EZETIMIBE (10.00mg), ROSUVASTATIN ZINC EQV ROSUVASTATIN (10.00mg)",NDA-2: New combination,SERVIER (S) PTE LTD,21/12/2023,"SIN16919P, SIN16920P"
"NGENLA SOLUTION FOR INJECTION IN A PRE-FILLED PEN 24 MG/1.2ML,NGENLA SOLUTION FOR INJECTION IN A PRE-FILLED PEN 60 MG/1.2ML","Somatrogon(24mg/1.2ml),Somatrogon(60mg/1.2ml)",NDA-1: New biological entityNDA-3: Subsequent strength,PFIZER PRIVATE LIMITED,14/12/2023,"SIN16911P, SIN16912P"
PLUVICTO SOLUTION FOR INJECTION/INFUSION 1000 MBQ/ML,Lutetium (177 Lu) vipivotide tetraxetan (1000 MBq/mL),NDA-1: New chemical entity,NOVARTIS (SINGAPORE) PTE LTD,18/12/2023,SIN16917P
"TRECONDI POWDER FOR SOLUTION FOR INFUSION 5 G PER VIAL,TRECONDI POWDER FOR SOLUTION FOR INFUSION 1 G PER VIAL","Treosulfan (5 g / vial),Treosulfan (1 g / vial)",NDA-1: New chemical entityNDA-3: Subsequent strength,LINK HEALTHCARE SINGAPORE PTE LTD,26/12/2023,"SIN16922P, SIN16923P"
TRELEGY ELLIPTA INHALATION POWDER 200 MCG/62.5 MCG/25 MCG,"FLUTICASONE FUROATE (MICRONISED)(200 MCG),UMECLIDINIUM BROMIDE (MICRONISED) EQV TO UMECLIDINIUM(62.5 MCG),VILANTEROL TRIFENATATE (MICRONISED) EQV TO VILANTEROL(25 MCG)",NDA-2: New presentation,GLAXOSMITHKLINE PTE LTD,15/12/2023,SIN16914P
ADRENALINE AGUETTANT SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 0.1 MG/ML,Adrenaline tartrate equivalent to adrenaline (0.1 mg/ml),NDA-2: New formulation / strength,AGUETTANT ASIA PACIFIC PTE. LTD.,07/11/2023,SIN16897P
AKYNZEO® IV CONCENTRATE FOR SOLUTION FOR INFUSION 235 MG/0.25 MG/VIAL,"Fosnetupitant Chloride Hydrochloride equivalent to Fosnetupitant (235mg/vial), Palonosetron hydrochloride equivalent to Palonosetron (0.25 mg/vial)",NDA-1: New chemical entity,JUNIPER BIOLOGICS PTE LTD,28/11/2023,SIN16899P
"LOCAMETZ 25 MICROGRAMS, KIT FOR RADIOPHARMACEUTICAL PREPARATION OF GALLIUM (68GA) GOZETOTIDE SOLUTION",Gozetotide (25?g/vial),NDA-1: New chemical entity,NOVARTIS (SINGAPORE) PTE LTD,30/11/2023,SIN16904P
TRAZHER (TRASTUZUMAB) POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 420MG/VIAL,Trastuzumab (420 mg/vial),NDA-3: New pack size,INNOGENE KALBIOTECH PTE. LTD.,22/11/2023,SIN16898P
GOOFICE FILM-COATED TABLET 5MG,Elobixibat,NDA-1: New chemical entity,EISAI (SINGAPORE) PTE. LTD.,02/10/2023,SIN16878P
PAXLOVID FILM-COATED TABLETS,"Nirmatrelvir, Ritonavir",NDA-1: New chemical entity(Transition from PSAR to marketing authorisation),PFIZER PRIVATE LIMITED,02/10/2023,SIN16877P
SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5(50 MICROGRAMS/50 MICROGRAMS)/ML DISPERSION FOR INJECTION,"Elasomeran, Davesomeran",NDA-1: New biological entity,MODERNA BIOTECH SINGAPORE PTE. LTD.,11/10/2023,SIN16881P
SPEVIGOCONCENTRATE FOR SOLUTION FOR INFUSION 450 MG/7.5 ML,Spesolimab,NDA-1: New biological entity,BOEHRINGER INGELHEIM SINGAPORE PTE. LTD.,12/10/2023,SIN16883P
"NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5µG/DOSE (RECOMBINANT, ADJUVANTED)",SARS-CoV-2 recombinant Spike Protein (rS),NDA-1: New biological entity,PHARMENG TECHNOLOGY PTE LTD,17/10/2023,SIN16886P
PERIOLIMEL N4E EMULSION FOR INFUSION,"(Compartment 1) Alanine 3.66g/L(Compartment 1) Arginine 2.48g/L(Compartment 1) Aspartic Acid 0.73g/L(Compartment 1) Glutamic Acid 1.26g/L(Compartment 1) Glycine 1.76g/L(Compartment 1) Histidine 1.51g/L(Compartment 1) Isoleucine 1.26g/L(Compartment 1) Leucine 1.76g/L(Compartment 1) Lysine Acetate eqv Lysine 1.99g/L(Compartment 1) Magnesium Chloride Hexahydrate 0.45g/L(Compartment 1) Methionine 1.26g/L(Compartment 1) Phenylalanine 1.76g/L(Compartment 1) Potassium Chloride 1.19g/L(Compartment 1) Proline 1.51g/L(Compartment 1) Serine 1.00g/L(Compartment 1) Sodium Acetate Trihydrate 1.16g/L(Compartment 1) Sodium Glycerophosphate, Hydrated 1.91g/L(Compartment 1) Threonine 1.26g/L(Compartment 1) Tryptophan 0.42g/L(Compartment 1) Tyrosine 0.06g/L(Compartment 1) Valine 1.62g/L(Compartment 2) Calcium Chloride Dihydrate 0.30g/L(Compartment 2) Glucose Monohydrate eqv Glucose Anhydrous 75.0g/L(Compartment 3) Refined Olive Oil + Soya-bean Oil (80:20) 30g/L",NDA-2: New combination,BAXTER HEALTHCARE (ASIA) PTE LTD,20/10/2023,SIN16888P
OLIMEL N7E EMULSION FOR INFUSION,"(Compartment 1) Alanine 6.41g/L(Compartment 1) Arginine 4.34g/L(Compartment 1) Aspartic Acid 1.28g/L(Compartment 1) Glutamic Acid 2.21g/L(Compartment 1) Glycine 3.07g/L(Compartment 1) Histidine 2.64g/L(Compartment 1) Isoleucine 2.21g/L(Compartment 1) Leucine 3.07g/L(Compartment 1) Lysine Acetate eqv Lysine 3.48g/L(Compartment 1) Magnesium Chloride Hexahydrate 0.81g/L(Compartment 1) Methionine 2.21g/L(Compartment 1) Phenylalanine 3.07g/L(Compartment 1) Potassium Chloride 2.24g/L(Compartment 1) Proline 2.64g/L(Compartment 1) Serine 1.75g/L(Compartment 1) Sodium Acetate Trihydrate 1.50g/L(Compartment 1) Sodium Glycerophosphate, Hydrated 3.67g/L(Compartment 1) Threonine 2.21g/L(Compartment 1) Tryptophan 0.74g/L(Compartment 1) Tyrosine 0.11g/L(Compartment 1) Valine 2.83g/L(Compartment 2) Calcium Chloride Dihydrate 0.52g/L(Compartment 2) Glucose Monohydrate eqv Glucose Anhydrous 140g/L(Compartment 3) Refined Olive Oil + Soya-bean Oil (80:20) 40g/L",NDA-3: Line extension,BAXTER HEALTHCARE (ASIA) PTE LTD,20/10/2023,SIN16889P
OLIMEL N9E EMULSION FOR INFUSION,"(Compartment 1) Alanine 8.24g/L(Compartment 1) Arginine 5.58g/L(Compartment 1) Aspartic Acid 1.65g/L(Compartment 1) Glutamic Acid 2.84g/L(Compartment 1) Glycine 3.95g/L(Compartment 1) Histidine 3.40g/L(Compartment 1) Isoleucine 2.84g/L(Compartment 1) Leucine 3.95g/L(Compartment 1) Lysine Acetate eqv Lysine 4.48g/L(Compartment 1) Magnesium Chloride Hexahydrate 0.81g/L(Compartment 1) Methionine 2.84g/L(Compartment 1) Phenylalanine 3.95g/L(Compartment 1) Potassium Chloride 2.24g/L(Compartment 1) Proline 3.40g/L(Compartment 1) Serine 2.25g/L(Compartment 1) Sodium Acetate Trihydrate 1.50g/L(Compartment 1) Sodium Glycerophosphate, Hydrated 3.67g/L(Compartment 1) Threonine 2.84g/L(Compartment 1) Tryptophan 0.95g/L(Compartment 1) Tyrosine 0.15g/L(Compartment 1) Valine 3.64g/L(Compartment 2) Calcium Chloride Dihydrate 0.52g/L(Compartment 2) Glucose Monohydrate eqv Glucose Anhydrous 110.0g/L(Compartment 3) Refined Olive Oil + Soya-bean Oil (80:20) 40g/L",NDA-3: Line extension,BAXTER HEALTHCARE (ASIA) PTE LTD,20/10/2023,SIN16890P
SKIIP NICOTINE MINI LOZENGE 2MG (MINT),Nicotine Polacrilex,NDA-2: New salt /dosage form,RUBICON RESEARCH PRIVATE LIMITED,30/10/2023,SIN16895P
COMIRNATY ORIGINAL/OMICRON BA.4-5 DISPERSION FOR INJECTION 15/15 MICROGRAMS/DOSE (MULTI-DOSE VIAL)COMIRNATY ORIGINAL/OMICRON BA.4-5 DISPERSION FOR INJECTION 15/15 MICROGRAMS/DOSE (SINGLE-DOSE VIAL),Tozinameran / Famtozinameran,NDA-1: New biological entityNDA-2: New dosage form,BIONTECH PHARMACEUTICALS ASIA PACIFIC PTE. LTD.,07/09/2023,"SIN16855P, SIN16856P"
ANDROGEL GEL 16.2MG/G,Testosterone,"NDA-2: New formulation, strength",PHARMED IMPORT & EXPORT PTE LTD,07/09/2023,SIN16857P
BONJESTA EXTENDED-RELEASE TABLETS 20MG/20MG,"Doxylamine Succinate, Pyridoxine Hydrochloride","NDA-2: New formulation, dosing regimen",UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED,18/09/2023,SIN16865P
KIRSTY™ SOLUTION FOR INJECTION IN VIAL 100 UNITS/MLKIRSTY™ SOLUTION FOR INJECTION IN PRE-FILLED PEN 100 UNITS/ML,Insulin aspart (rDNA origin),NDA-2: Biosimilar,MYLAN PHARMACEUTICALS PTE. LTD.,20/09/2023,"SIN16867P, SIN16868P"
SKYRIZI CONCENTRATE FOR SOLUTION FOR INFUSION 600MG/10MLSKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED CARTRIDGE WITH ON-BODY INJECTOR 360MG/2.4ML,Risankizumab,"NDA-2: New presentation, strength, indication, dosing regimen",ABBVIE PTE. LTD.,27/09/2023,"SIN16869P, SIN16870P"
OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML,Ocrelizumab,NDA-1: New chemical entity,ROCHE SINGAPORE PTE LTD,28/09/2023,SIN16871P
CALQUENCE FILM-COATED TABLET 100MG,Acalabrutinib,NDA-2: New dosage form,ASTRAZENECA SINGAPORE PTE LTD,29/09/2023,SIN16875P
NAGLAZYME CONCENTRATE FOR SOLUTION FOR INFUSION,Galsulfase,NDA-1: New biological entity,PHARM-D SINGAPORE PRIVATE LIMITED,11/08/2023,SIN16831P
ABILIFY MAINTENA POWDER AND SOLVENT FOR PROLONGED RELEASE SUSPENSION FOR INJECTION IN PFS 400 MG,Aripiprazole,NDA-2: New dosage form,LUNDBECK SINGAPORE PTE LTD,14/08/2023,SIN16832P
ABILIFY MAINTENA POWDER AND SOLVENT FOR PROLONGED RELEASE SUSPENSION FOR INJECTION IN PFS 400 MG,Aripiprazole,NDA-2: New dosage form,LUNDBECK SINGAPORE PTE LTD,14/08/2023,SIN16832P
SPIKEVAX 0.2 mg/mL DISPERSION FOR INJECTION,Elasomeran,NDA-1: New biological entity(Transition from PSAR to marketing authorisation),MODERNA BIOTECH SINGAPORE PTE. LTD.,17/08/2023,SIN16834P
SPIKEVAX 0.1 mg/mL DISPERSION FOR INJECTION,Elasomeran,NDA-2: New strength(Transition from PSAR to marketing authorisation),MODERNA BIOTECH SINGAPORE PTE. LTD.,17/08/2023,SIN16835P
GALLIAPHARM RADIONUCLIDE GENERATOR 0.74 – 1.85 GBq,Germanium (68Ge) chloride; Gallium (68Ga) chloride,NDA-1: New chemical entity,LABGISTICS ASIA PTE LTD,23/08/2023,SIN16844P
IMJUDO CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML,Tremelimumab,NDA-1: New biological entity,ASTRAZENECA SINGAPORE PTE LTD,25/08/2023,SIN16845P
SELENIUM AGUETTANT CONCENTRATE FOR SOLUTION FOR INFUSION 10 MCG/ML,Sodium Selenite,NDA-2: New presentation,AGUETTANT ASIA PACIFIC PTE. LTD.,27/08/2023,SIN16847P
OPDUALAG CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/80MG,Nivolumab/relatlimab,NDA-1: New biological entity,BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.,31/08/2023,SIN16852P
"RHOPRESSA OPHTHALMIC SOLUTION, STERILE 0.02%",Netarsudil mesylate,NDA-1: New chemical entity,SANTEN PHARMACEUTICAL ASIA PTE LTD,4/7/2023,SIN16816P
"ROCKLATAN OPHTHALMIC SOLUTION, STERILE 0.02%/0.005%",Netarsudil mesylate/Latanoprost,NDA-2: New combination,SANTEN PHARMACEUTICAL ASIA PTE LTD,4/7/2023,SIN16818P
TEZSPIRE SOLUTION FOR INJECTION 210MG (PRE-FILLED SYRINGE),Tezepelumab,NDA-1: New chemical entity,ASTRAZENECA SINGAPORE PTE LTD,4/7/2023,SIN16815P
TEZSPIRE SOLUTION FOR INJECTION 210MG (PRE-FILLED PEN),Tezepelumab,NDA-2: New presentation,ASTRAZENECA SINGAPORE PTE LTD,4/7/2023,SIN16817P
BRAFTOVI HARD CAPSULE 50 MG AND 75 MG,Encorafenib,NDA-1/3: New chemical entity and strength,ZUELLIG PHARMA PTE. LTD.,19/7/2023,SIN16824P and SIN16825P
MEKTOVI FILM-COATED TABLET 15MG,Binimetinib,NDA-1: New chemical entity,ZUELLIG PHARMA PTE. LTD.,19/7/2023,SIN16826P
VITRAKVI ORAL SOLUTION 20MG/ML,Larotrectinib sulfate eqv Larotrectinib,NDA-2: New formulation,Bayer (South East Asia) Pte Ltd,28/7/2023,SIN16827P
SONDELBAY INJECTION 20 MCG/80 MCL,Teriparatide,NDA-2: Biosimilar,ACCORD HEALTHCARE PRIVATE LIMITED,01/06/2023,SIN16802P
CAMZYOS CAPSULES 2.5MGCAMZYOS CAPSULES 5MGCAMZYOS CAPSULES 10MGCAMZYOS CAPSULES 15MG,Mavacamten,NDA-1: New chemicalNDA-3: New strength,LIANBIO DEVELOPMENT (SG) PTE. LTD.,14/06/2023,"SIN16804P, SIN16805P, SIN16806P, SIN16807P"
VEGZELMA CONCENTRATE FOR SOLUTION FOR INFUSION 25 MG/ML,Bevacizumab,NDA-2: Biosimilar,CELLTRION HEALTHCARE SINGAPORE PRIVATE LIMITED,16/06/2023,SIN16810P
NUCALA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 40MG/0.4ML,Mepolizumab,NDA-2: New strength / indication / dosing regimen,GLAXOSMITHKLINE PTE LTD,19/06/2023,SIN16811P
ELELYSO POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 200 UNITS/ VIAL,Taliglucerase alfa,NDA-1: New biological entity,PFIZER PRIVATE LIMITED,03/05/2023,SIN16770P
ZEPOSIA CAPSULE 0.92MGZEPOSIA CAPSULES TREATMENT INITIATION PACK,Ozanimod Hydrochloride,NDA-1: New chemical entityNDA-2: New strength,BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD,17 May 2023,"SIN16785P, SIN16786P"
"BERIPLAST P COMBI-SET POWDERS AND SOLVENTS FOR SEALANT 1.0ML, 3.0ML",1.0mlVial 1: Factor XIII 60IU/mLVial 1: Fibrinogen: 90mg/mLVial 2: Aprotinin solution 1000KIU/mLVial 3: Thrombin 500IU/mLVial 4: Calcium chloride dihydrate 5.9mg/mL3.0mlVial 1: Factor XIII 180IU/mLVial 1: Fibrinogen: 270mg/mLVial 2: Aprotinin solution 3000KIU/mLVial 3: Thrombin 1500IU/mLVial 4: Calcium chloride dihydrate 17.7mg/mL,"NDA-2/3: New product containing a currently registered entity, new strength",CSL BEHRING PTE. LTD.,10/05/2023,"SIN16775P, SIN16776P"
GAVRETO HARD CAPSULE 100MG,Pralsetinib,NDA-1,ROCHE SINGAPORE PTE LTD,06 April 2023,SIN16755P
ALBUMIN SG INJECTION 20%,Human serum albumin,NDA-2,THE REG CONSULTANTS PTE LTD,20 April 2023,SIN16765P
IMMUNOGLOBULIN SG INJECTION 50MG/ML,Human immunoglobulin G,NDA-2,THE REG CONSULTANTS PTE LTD,20 April 2023,SIN16766P
DEXDOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 MICROGRAMS/ML,Dexmedetomidine,NDA-2,ORION PHARMA (SG) PTE. LTD.,25 April 2023,SIN16767P
ZINC AGUETTANT CONCENTRATE FOR SOLUTION FOR INJUSION 1MG/ML,Zinc gluconate equivalent to elemental zinc,NDA-2,AGUETTANT ASIA PACIFIC PTE LTD,25 April 2023,SIN16768P
QINLOCK TABLET 50 MG,Ripretinib,NDA-1,SPECIALISED THERAPEUTICS ASIA PTE LTD,28 April 2023,SIN16769P
"MOUNJARO INJECTION 2.5MG/0/5ML, 5MG/0.5ML, 7.5MG/0.5ML, 10MG/0.5ML, 12.5MG/0.5ML AND 15MG/0.5ML",Tirzepatide,NDA-1: New chemical entityNDA-3: New strength,DKSH SINGAPORE PTE. LTD.,01/03/2023,"SIN16714P, SIN16716P, SIN16717P, SIN16718P, SIN16719P AND SIN16720P"
BREZTRI AEROSPHERE PRESSURISED INHALATION SUSPENSION 160 MCG/7.2 MCG/5 MCG PER ACTUATION,"Budesonide, glycopyrronium, formoterol",NDA-2: New combination,ASTRAZENECA SINGAPORE PTE LTD,01/03/2023,SIN16723P
"LEUPRORELIN SANDOZ IMPLANT IN SYRINGE 3.6 MG, 5 MG",Leuprorelin acetate eqv leuprorelin,NDA-2: New dosage formNDA-3: New strength,NOVARTIS (SINGAPORE) PTE LTD,21/03/2023,"SIN16740P, SIN16739P"
"WEGOVY 0.25MG, 0.5MG, 1.0MG, 1.7MG and 2.4MG FLEXTOUCH SOLUTION FOR INJECTION in PRE-FILLED PEN",Semaglutide,NDA-2: New product containing registered entityNDA-3: New strength,NOVO NORDISK PHARMA (SINGAPORE) PTE LTD,24/03/2023,"SIN16744P, SIN16745P, SIN16746P, SIN16747P and SIN16748P"
SPINRAZA SOLUTION FOR INJECTION 12MG/5ML,Nusinersen sodium,NDA-1: New chemical entity,ZUELLIG PHARMA PTE. LTD.,31/03/2023,SIN16751P
RINVOQ EXTENDED-RELEASE TABLET 45MG,Upadacitinib Hemihydrate eqv Upadacitinib,NDA-3: New strength,ABBVIE PTE LTD,10 Feb 2023,SIN16687P
"MENOPUR SOLUTION FOR INJECTION IN PRE-FILLED PEN 600 IU, 1200 IU",Menotrophin,"NDA-2/3: New formulation, new strength",Ferring Pharmaceuticals Private Limited,20 Feb 2023,SIN16699PSIN16700P
NURTEC ORALLY DISINTEGRATING TABLET 75MG,Rimegepant sulfate eqv Rimegepant,NDA-1: New chemical entity,PFIZER PRIVATE LIMITED,21 Feb 2023,SIN16702P
MAXIGESIC PE FILM-COATED TABLET,"Paracetamol, phenylephrine hydrochloride, ibuprofen",NDA-2: New combination,APEX PHARMA MARKETING PTE. LTD.,21 Feb 2023,SIN16703P
WEGOVY 1MG SOLUTION FOR INJECTION IN PRE-FILLED PENWEGOVY 0.5MG SOLUTION FOR INJECTION IN PRE-FILLED PENWEGOVY 0.25MG SOLUTION FOR INJECTION IN PRE-FILLED PENWEGOVY 1.7MG SOLUTION FOR INJECTION IN PRE-FILLED PENWEGOVY 2.4MG SOLUTION FOR INJECTION IN PRE-FILLED PEN,Semaglutide,"NDA-2/3: New strength, new indication",NOVO NORDISK PHARMA (SINGAPORE) PTE LTD,22 Feb 2023,SIN16704PSIN16705PSIN16706PSIN16707PSIN16708P
NOVOEIGHT POWDER AND SOLVENT FOR SOLUTIONFOR INJECTION 2000IU/VIAL,Turoctocog Alfa,NDA-3: New strength,NOVO NORDISK PHARMA (SINGAPORE) PTE LTD,24 Feb 2023,SIN16713P
"TROKENDI XR EXTENDED-RELEASE CAPSULE 25MG, 50MG, 100MG, 200MG",Topiramate,NDA-2: New dosage formNDA-3: New strength,ORIENT EUROPHARMA PTE LTD,05/01/2023,"SIN16662P, SIN16663P, SIN16664P, SIN16665P"
SUVEZEN 10 MG/10 MG FILM-COATED TABLETSSUVEZEN 20 MG/10 MG FILM-COATED TABLETS,"Rosuvastatin, Ezetimibe",NDA-2: New dosage formNDA-3: New strength,SANOFI-AVENTIS SINGAPORE PTE. LTD.,05/01/2023,"SIN16660P, SIN16661P"
K-CAB FILM-COATED TABLETS 50MG,Tegoprazan,NDA-1: New chemical entity,UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED,11/01/2023,SIN16672P
ENTYVIO POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/VIAL,Vedolizumab,NDA-2: New dosage form /dosing regimen,TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.,11/01/2023,SIN16673P
NABOTA POWDER FOR SOLUTION FOR INJECTION 100 UNITS/VIAL,Clostridium Botulinum Toxin Type A,NDA-2: New biological product,HYPHENS PHARMA PTE. LTD.,20/01/2023,SIN16680P
FESPIXON CREAM,"Centella asiatica extract, Plectranthus amboinicusextract",NDA-1,PHARMENG TECHNOLOGY PTE. LTD.,31/01/2023,SIN16683P
"LYPSTAPLUS FILM-COATED TABLET 20MG/10MG, 10MG/10MG","Rosuvastatin, ezetimibe",NDA-2: New combination,ABBOTT LABORATORIES (SINGAPORE) PRIVATE LIMITED,06/12/2022,"SIN16650P, SIN16651P"
ASADIN INJECTION 1 MG/ML,Arsenic Trioxide,NDA-1: New chemical entity,PHARM-D SINGAPORE PTE LTD,02/11/2022,SIN16634P
HIBRUKA TABLET 50 MG,Orelabrutinib,NDA-1: New chemical entity,LABCORP DEVELOPMENT (ASIA) PTE. LTD.,22/11/2022,SIN16645P
APEXXNAR SUSPENSION FOR INJECTION IN SINGLE-DOSE PRE-FILLED SYRINGE 0.5ML,"Pneumococcal polysaccharide of serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, 33F conjugated to CRM197carrier protein, adsorbed on aluminium phosphate.",NDA-1: New biological entity,PFIZER PRIVATE LIMITED,30/11/2022,SIN16648P
JEMPERLI CONCENTRATE FOR SOLUTION FOR INFUSION 500MG/10ML,Dostarlimab,NDA-1: New biological entity,GLAXOSMITHKLINE PTE LTD,06/10/2022,SIN16623P
SARCLISA CONCENTRATE FOR SOLUTION FOR INFUSION20MG/ML,Isatuximab,NDA-1: New biological entity,SANOFI-AVENTIS SINGAPORE PTE. LTD,17 OCT 2022,SIN16630P
Trazher (trastuzumab) Powder for Concentrate for Solution for Infusion 150mg/vial,Trastuzumab,NDA-2,INNOGENE KALBIOTECH PTE. LTD.,09/10/2022,SIN16631P
DUCRESSA EYE DROPS SOLUTION 1MG/ML + 5MG/ML,Dexamethasone sodium phosphate 1.32mg/mL (eqv to Dexamethasone 1.00mg/mL)Levofloxacin hemihydrate 5.12mg/mL (eqv to Levofloxacin 5.00mg/Ml),NDA-2: New combination,SANTEN PHARMACEUTICAL ASIA PTE LTD,07/09/2022,SIN16596P
BLENREP POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG,Belantamab mafodotin,NDA-1,GLAXOSMITHKLINE PTE LTD,21/09/2022,SIN16606P
"JINARC TABLET 15MG, 30MG, 45MG/15MG, 60MG/30MG, 90MG/30MG",Tolvaptan,NDA-2/3: New indication/strength/dosing regimen,Otsuka Pharmaceuticals (Singapore) Pte. Ltd.,23 Sep 22,"SIN16607P, SIN16608P, SIN16609P, SIN16610P, SIN16611P"
STAQUIS OINTMENT 2% W/W,Crisaborole,NDA-1: New chemical entity,PFIZER PRIVATE LIMITED,27/09/2022,SIN16613P
EQUFINA FILM-COATED TABLETS 50MG,Safinamide,NDA-1: New chemical entity,EISAI (SINGAPORE) PTE. LTD.,28/09/2022,SIN16615P
INREBIC CAPSULES 100MG,Fedratinib,NDA-1: New chemical entity,Bristol-Myers Squibb (Singapore) Pte Ltd,29 Sep 2022,SIN16617P
"COMIRNATY, CONCENTRATE FOR DISPERSION FOR INJECTION, 3 MCG/DOSE",Tozinameran,NDA-2: New formulation and patient population,BIONTECH PHARMACEUTICALS ASIA PACIFIC PTE.LTD.,28 Sep 2022,SIN16616P
ABRILADA SOLUTION FOR INJECTION IN SINGLE-DOSE PREFILLED SYRINGE 20MG/0.4 MLABRILADA SOLUTION FOR INJECTION IN SINGLE-DOSE PREFILLED PEN 40 MG/0.8 MLABRILADA SOLUTION FOR INJECTION IN SINGLE-DOSE PREFILLED SYRINGE 40MG/0.8 ML,Adalimumab,NDA-2/3,PFIZER PRIVATE LIMITED,02/08/2022,"SIN16561P, SIN16562P, SIN16563P"
NICORETTE QUICKMIST MOUTHSPRAY 1MG/SPRAY,Nicotine,NDA-2*: New dosage form,JOHNSON & JOHNSON PTE LTD,06/08/2022,SIN16567P
REKAMBYS PROLONGED-RELEASE SUSPENSION FOR INJECTION 300MG/ML,Rilpivirine,NDA-2*: New dosage form,JOHNSON & JOHNSON PTE LTD,11/08/2022,SIN16568P
AKLIEF CREAM 50 MCG/G,Trifarotene,NDA-1,GALDERMA SINGAPORE PRIVATE LIMITED,17/08/2022,SIN16571P
ONUREG FILM-COATED TABLETS 200MGONUREG FILM-COATED TABLETS 300MG,Azacitidine,NDA-2/3,BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.,19/08/2022,SIN16572PSIN16573P
BRINTELLIX ORAL DROPS SOLUTION 20 MG/ML,Vortioxetine,NDA-2: New dosage form,LUNDBECK SINGAPORE PTE. LTD.,22/08/2022,SIN16577P
KORSUVA SOLUTION FOR INJECTION 50 MCG/ML,Difelikefalin,NDA-1: New chemical entity,VIFOR PHARMA ASIA PACIFIC PTE. LTD.,25/08/2022,SIN16582P
"YULAREB FILM-COATED TABLET 50MG, 100MG, 150MG",Abemaciclib,NDA-2 and NDA-3,DKSH SINGAPORE PTE. LTD.,22/08/2022,"SIN16574P, SIN16575P, SIN16576P"
ABEVMY™ CONCENTRATE FOR SOLUTION FOR INFUSION 25MG/ML,Bevacizumab,NDA-2,MYLAN PHARMACEUTICALS PTE. LTD.,29/08/2022,SIN16583P
NEPEXTO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 25MG/0.5MLNEPEXTO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 50MG/MLNEPEXTO SOLUTION FOR INJECTION IN PRE-FILLED PEN 50MG/ML,Etanercept,NDA-2: BiosimilarNDA-3: Subsequent strength,MYLAN PHARMACEUTICALS PTE. LTD.,04/07/2022,SIN16531PSIN16532PSIN16533P
FORTACIN CUTANEOUS SPRAY SOLUTION 7.5MG/DOSE + 2.5MG/DOSE,Lidocaine/Prilocaine,NDA-2: New dosage form/indication,Orient Europharma,5/7/2022,SIN16538P
VOCABRIA FILM-COATED TABLETS 30MGVOCABRIA PROLONGED-RELEASE SUSPENSION FOR INJECTION 600 MG/3 MLVOCABRIA PROLONGED-RELEASE SUSPENSION FOR INJECTION 400 MG/ 2 ML,Cabotegravir,NDA-1: New chemical entity,GLAXOSMITHKLINE PTE LTD,5/7/2022,"SIN16541P, SIN16542P, SIN16543P"
"SCEMBLIX FILM-COATED TABLET 20 MG, SCEMBLIX FILM-COATED TABLET 40 MG",Asciminib hydrochloride,NDA-1: New chemical entityNDA-3: New strength,NOVARTIS (SINGAPORE) PTE LTD,05/07/2022,"SIN16539P, SIN16540P"
SALONPAS DICLOFENAC PATCH 15MG,Diclofenac Sodium,NDA-2: New dosage form,"Hisamitsu Pharmaceutical Co., Inc. Singapore Branch",07/070/2022,SIN16546P
RYBREVANT CONCENTRATE FOR SOLUTION FOR INFUSION 350MG/7ML,Amivantamab 50mg/ml,NDA-1: New biological entity,JOHNSON & JOHNSON PTE. LTD.,13/07/2022,SIN16548P
TEPADINA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/VIALTEPADINA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 15 MG/VIAL,Thiotepa,NDA-1: New chemical entityNDA-3: New strength,AXXESSBIO PTE LID,18/7/2022,SIN16552PSIN16553P
ROZEVON FILM-COATED TABLET 40MG/10MGROZEVON FILM-COATED TABLET 20MG/10MGROZEVON FILM-COATED TABLET 10MG/10MGROZEVON FILM-COATED TABLET 5MG/10MG,Active ingredient,NDA-2: New combination,NOVEM PHARMA PRIVATE LIMITED,04/07/2022,SIN16534PSIN16535PSIN16536PSIN16537P
PRIMOVIST SOLUTION FOR INJECTION IN VIAL 0.25 mmol/ml,"Gadoxetate, disodium",NDA-2: New presentation,BAYER (SOUTH EAST ASIA) PTE LTD,21/07/2022,SIN16559P
MAXIGESIC IV SOLUTION FOR INFUSION 1000MG/300MG PER 100ML VIAL,Ibuprofen sodium dihydrate/ Paracetamol,NDA-2: New combination,APEX PHARMA MARKETING PTE. LTD.,03/06/2022,SIN16507P
YUFLYMA SOLUTION FOR INJECTION IN PRE-FILLED PEN 40MG/0.4ML,Adalimumab,NDA-2,CELLTRION HEALTHCARE SINGAPORE PRIVATE LIMITED,09/06/2022,SIN16508P
FYCOMPA ORAL SUSPENSION 0.5MG/ML,Perampanel,NDA-2,EISAI (SINGAPORE) PTE LTD,10/06/2022,SIN16512P
VABYSMO SOLUTION FOR INJECTION 6 MG/0.05 ML,Faricimab,NDA-1: New biological entity,ROCHE SINGAPORE PTE. LTD.,16/06/2022,SIN16514P
LUMAKRAS FILM-COATED TABLET 120MG,Sotorasib,NDA-1: New chemical entity,AMGEN BIOTECHNOLOGY SINGAPORE PTE LTD,28/06/2022,SIN16522P
RYALTRIS NASAL SPRAY 600/25MCG,"Mometasone furoate monohydrate, Olopatadine HCl",NDA-2: New combination,GLENMARK PHARMACEUTICALS SINGAPORE PTE. LTD.,28/06/2022,SIN16523P
RINVOQ EXTENDED-RELEASE TABLETS 30MG,Upadacitinib hemihydrate equivalent to Upadacitinib,NDA-3: New strength,ABBVIE PTE LTD,21/06/2022,SIN16518P
XARELTO GRANULES FOR ORAL SUSPENSION 1MG/ML,Rivaroxaban,NDA-2: New dosage form,BAYER (SOUTH EAST ASIA) PTE LTD,06 May 2022,SIN16487P
NOXBETA TABLET 5 MG,Nebivolol (as nebivolol hydrochloride),NDA-2: New brand,A. MENARINI SINGAPORE PTE. LTD.,06 May 2022,SIN16486P
PARMODIA FILM-COATED TABLETS 0.1 MG,Pemafibrate,NDA-1,DKSH SINGAPORE PTE. LTD.,18 May 2022,SIN16492P
PADCEV POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 20MG AND 30MG,Enfortumab vedotin,NDA-1,ASTELLAS PHARMA SINGAPORE PTE. LTD.,30 May 2022,"SIN16502P, SIN16503P"
TIVICAY DISPERISBLE TABLET 5MG,Dolutegravir,NDA-2,GLAXOSMITHKLINE PTE LTD,30 May 2022,SIN16504P
BOOSTAGEN SUSPENSION FOR INJECTION,"Diphtheria Toxoid (DT)(2.0 Lf / 0.5ml), Filamentous Haemagglutinin (FHA)(5ug/0.5ml), Recombinant Pertussis Toxin (rPT)(5ug/0.5ml), Tetanus Toxoid (TT)(7.5 Lf/0.5ml)",NDA-1,NOVEM HEALTHCARE PTE LTD,18/05/2022,SIN16493P
"ZEJULA FILM-COATED TABLET 100MG, 200MG, 300MG",Niraparib,NDA-1: New chemical entityNDA-3: New strength,GLAXOSMITHKLINE PTE LTD,01/04/2022,"SIN16459P, SIN16460P, SIN16461P"
HIBOR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGES 3500 IU ANTI-XA/0.2 MLHIBOR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGES 2500IU ANTI-XA/0.2ML,Bemiparin Sodium,NDA-1: New chemical entityNDA-3: New strength,DCH AURIGA SINGAPORE,01/04/2022,"SIN16462P, SIN16463P"
B.BRAUN IBUPROFEN SOLUTION FOR INFUSION 4MG/ML,Ibuprofen,NDA-2: New dosage form,B.BRAUN SINGAPORE PTE LTD,04/04/2022,SIN16467P
REBLOZYL POWDER FOR SOLUTION FOR INJECTION 25MG/VIAL AND 75MG/VIAL,Luspatercept,NDA-1: New biological entityNDA-3: New strength,BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.,06/04/2022,"SIN16470P, SIN16471P"
GONAL-F 150 IU/0.25 ML (11 MICROGRAMS/0.25 ML) SOLUTION FOR INJECTION IN PRE-FILLED PEN,Follitropin alfa,NDA-3: New strength,MERCK PTE. LTD,11/04/2022,SIN16473P
ALIGRIN TABLET 20MG,Bilastine,NDA-2,A. MENARINI SINGAPORE PTE LTD,12/04/2022,SIN16474P
XPOVIO FILM-COATED TABLETS 20MG,Selinexor,NDA-1: New chemical/biological entity,ANTENGENE SINGAPORE PTE LTD,01/03/2022,SIN16434P
VANCOVER CAPSULE 125MG AND 250MG,Vancomycin,NDA-2/3: New formulation and new strength,ORIENT EUROPHARMA PTE LTD,11/03/2022,SIN16444P and SIN16445P
PRONAXEN ORAL SUSPENSION 25MG/ML,Naproxen,NDA-2: New formulation,ORION PHARMA (SG) PTE LTD,23/03/2022,SIN16449P
RUXIENCE CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/ML AND 500MG/50ML,Rituximab,NDA-2: Biosimilar,PFIZER PRIVATE LIMITED,25/03/2022,SIN16451P and SIN16452P
"MENQUADFI - MENINGOCOCCOL VACCINE, SOLUTION FOR INJECTION IN 0.5 ML VIAL",Neisseria meningitidis group A polysaccharide 10 µgNeisseria meningitidis group C polysaccharide 10 µgNeisseria meningitidis group Y polysaccharide 10 µgNeisseria meningitidis group W polysaccharide 10 µgConjugated to tetanus toxoid carrier protein 55 µg,NDA-2: New Dosage,SANOFI-AVENTIS SINGAPORE PTE. LTD.,29/03/2022,SIN16454P
DUPIXENT SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE 100MG/0.67ML,Dupilumab,NDA-2: New formulation,SANOFI-AVENTIS SINGAPORE PTE. LTD.,30/03/2022,SIN16458P
LUCONAC EXTERNAL SOLUTION FOR NAILS 5% W/W,Luliconazole,NDA-1: New chemical,ZUELLIG PHARMA PTE LTD,14/02/2022,SIN16428P
CONTRAVE PROLONGED RELEASE TABLET 8MG/90MG,Naltrexone hydrochloride / bupropion hydrochloride,NDA-2: New combination,INOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED,03/01/2022,SIN16411P
"CIBINQO FILM COATED TABLETS 50MG, 100MG, 200MG",Abrocitinib,NDA-1: New chemical entityNDA-3: New strength,PFIZER PRIVATE LIMITED,05/01/2022,"SIN16412P, SIN16413P, SIN16414P"
SALONPAS DICLOFENAC GEL 1%,Diclofenac,NDA-2: New dosage form,"HISAMITSU PHARMACEUTICAL CO., INC SINGAPORE BRANCH",17/01/2022,SIN16418P
TRODELVY POWDER FOR SOLUTION FOR INFUSION 180 MG/VIAL,Sacituzumab govitecan,NDA-1: New biological entity,EVEREST MEDICINES (SINGAPORE) PTE. LTD.,31/01/2022,SIN16425P
NUFILONG SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE 6MG/0.6ML,Pegfilgrastim,NDA-2: Biosimilar,PHARMA TO MARKET PTE. LTD,07/12/2021,SIN16393P
COMIRNATY DISPERSION FOR INJECTION 30MCG/DOSECOMIRNATY CONCENTRATE FOR DISPERSION FOR INJECTION 10MCG/DOSE,Tozinameran,NDA-1/2: New biological entity,BIONTECH PHARMACEUTICALS ASIA PACIFIC PTE LTD,10/12/2021,"SIN16396P, SIN16397P"
ONCASPAR POWDER FOR SOLUTION FOR INJECTION / INFUSION 750 U/ML,Pegaspargase,NDA-1: New biological entity,SERVIER (S) PTE LTD,27/12/2021,SIN16408P
SLINDA FILM-COATED TABLETS 4MG,Drospirenone,NDA-2,Intega Pte Ltd,01/11/2021,SIN16354P
COSENTYX SOLUTION FOR INJECTION IN PRE-FILLED UNOREADY PEN 300MG/2MLCOSENTYX SOLUTION FOR INJECTION IN PREFILLED SYRINGE 300MG/2ML,Secukinumab,NDA-2 and NDA-3,Novartis (Singapore) Pte Ltd,02/11/2021,"SIN16358P, SIN16359P"
HULIO SOLUTION FOR INJECTION 40MG/0.8ML IN PRE-FILLED SYRINGEHULIO SOLUTION FOR INJECTION 40MG/0.8ML IN PRE-FILLED PEN,Adalimumab,NDA-2,Mylan Pharmaceuticals Pte. Ltd.,02/11/2021,"SIN16360P, SIN16361P"
DOMIDE CAPSULES 50mg,Thalidomide,NDA-1: New chemical entity,PHARM-D SINGAPORE PRIVATE LIMITED,02/11/2021,SIN16362P
CANHERA LYOPHILIZED POWDER FOR INJECTION 440MG,Trastuzumab,NDA-2,Pharma To Market Pte Ltd,25 Nov 2021,SIN16384P
KERENDIA FILM-COATED TABLET 10 MGKERENDIA FILM-COATED TABLET 20 MG,Finerenone,NDA-1 and NDA-3,BAYER (SOUTH EAST ASIA) PTE LTD,25/11/2021,"SIN16387P, SIN16388P"
TEPMETKO FILM-COATED TABLET 225 MG,Tepotinib,NDA-1,Merck Pte Ltd,25/11/2021,SIN16386P
"SKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150MG/ML,SKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED PEN 150MG/ML",Risankizumab,NDA-2: New dosage form / strength,ABBVIE PTE. LTD.,01/10/2021,"SIN16338P, SIN16339P"
BRUKINSA CAPSULE 80MG,Zanubrutinib,NDA-1: New chemical entity,BEIGENE SINGAPORE PTE. LTD.,01/10/2021,SIN16341P
"VERQUVO FILM-COATED TABLET 10MG, 5MG, 2.5MG",Vericiguat,NDA-1: New chemical entityNDA-3: New strength,BAYER (SOUTH EAST ASIA) PTE LTD,01/10/2021,"SIN16340P, SIN16342P, SIN16343P"
AJOVY SOLUTION FOR INJECTION IN PRE-FILLED PEN 225 MG/1.5 ML,Fremanezumab,NDA-2*: New presentation,TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.,04/10/2021,SIN16344P
POLIVY POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 30 MG,Polatuzumab vedotin,NDA-3: New strength,ROCHE SINGAPORE PTE. LTD.,05/10/2021,SIN16345P
LATUDA TABLET 20MG,Active ingredient,NDA-3: New strength,DKSH SINGAPORE PTE. LTD.,12/10/2021,SIN16346P
ENSPRYNG SOLUTION FOR INJECTION IN PREFILLED SYRINGE 120MG/1ML,Satralizumab,NDA-1,ROCHE SINGAPORE PTE. LTD.,19/10/2021,SIN16348P
EVRYSDI POWDER FOR ORAL SOLUTION 0.75MG/ML,Risdiplam,NDA-1: New chemical entity,ROCHE SINGAPORE PTE. LTD.,20/10/2021,SIN16349P
"TABRECTA FILM-COATED TABLET 150mg,TABRECTA FILM-COATED TABLET 200mg",Capmatinib,NDA-1: New chemical entityNDA-3: New strength,NOVARTIS (SINGAPORE) PTE LTD,22/10/2021,"SIN16350P, SIN16351P"
ENHERTU POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL,Trastuzumab deruxtecan,NDA-1: New biological entity,ASTRAZENECA SINGAPORE PTE LTD,22/10/2021,SIN16352P
PROVEBLUE SOLUTION FOR INJECTION 5MG/ML,Methylthioninium chloride trihydrate (methylene blue),NDA-1: New chemical/biological entity,PHARM-D SINGAPORE PRIVATE LIMITED,03/09/2021,SIN16319P
DAYVIGO FILM-COATED TABLET 5MG AND 10MG,Lemborexant,NDA-1: New chemical entityNDA-3: New strength,Eisai (Singapore) Pte Ltd,15/09/2021,"SIN16320P, SIN16321P"
"Ibrance Film Coated Tablet 75 mg, 100 mg, 125 mg",Palbociclib,NDA-2: New dosage form,Pfizer Private Limited,15/09/2021,"SIN16322P, SIN16323P, SIN16324P"
VYEPTI CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/ML,Eptinezumab,NDA-1: New biological entity,LUNDBECK SINGAPORE PTE LTD,16 /09/2021,SIN16325P
TAKIPRIL SOLUTION FOR INJECTION 20MG/ML,Prilocaine hydrochloride,NDA-2: New strength / combination,B. BRAUN SINGAPORE PTE LTD,17/09/2021,SIN16326P
ZEPZELCA POWDER FOR SOLUTION FOR INFUSION 4MG/VIAL,Lurbinectedin,NDA-1: New chemical entity,Specialised Therapeutics Asia Pte Ltd,21/09/2021,SIN16327P
INHIXA SOLUTION FOR INJECTION 8000 ANTI-Xa IU (80MG)/0.8ML,Enoxaparin Sodium,NDA-2: New dosage form,HC HEALTHCARE PTE. LTD.,22/09/2021,SIN16331P
YUPELRI INHALATION SOLUTION 175MCG/3ML,Revefenacin,NDA-1: New chemical entity,MYLAN PHARMACEUTICALS PTE. LTD.,28/09/2021,SIN16336P
COSENTYX POWDER FOR SOLUTION FOR INJECTION IN PREFILLED SYRINGE 75MG/0.5ML,Secukinumab,NDA-3: New strength,Novartis (Singapore) Pte Ltd,1 Sep 21,SIN16315P
LEQVIO SOLUTION FOR INJECTION IN PREFILLED SYRINGE 284 MG/1.5 ML,Inclisiran sodium eqv inclisiran,NDA-1: New chemical entity,NOVARTIS (SINGAPORE) PTE LTD,03/08/2021,SIN16295P
HYRIMOZ SOLUTION FOR INJECTION IN PRE-FILLED PEN 40MG/0.8ML,Adalimumab,NDA-2: New dosage form,NOVARTIS (SINGAPORE) PTE LTD,08/07/2021,SIN16273P
"TECHNESCAN PYP, KIT FOR RADIOPHARMACEUTICAL PREPARATION, 20MG/VIAL",Sodium pyrophosphate decahydrate,NDA-1: New chemical entity,LICENCE HOLDER IN CAPS,09/07/2021,SIN16274P
KOSELUGO HARD CAPSULES 10MG/ 25MG,Selumetinib,NDA-1/ 3,ASTRAZENECA SINGAPORE PTE LTD,09/07/2021,"SIN16275P, SIN16276P"
PERTAGEN SUSPENSION FOR INJECTION,"Filamentous Haemagglutinin, Recombinant Pertussis Toxin",NDA-2,NOVEM HEALTHCARE PTE LTD,23/07/2021,SIN16283P
"ZIRABEV SOLUTION FOR INJECTION 100 mg/4 mL,ZIRABEV SOLUTION FOR INJECTION 400 mg/16 mL",Bevacizumab (PF-06439535),NDA-2/3,PFIZER PRIVATE LIMITED,26/07/2021,"SIN16286P, SIN16287P"
ACCOFIL SOLUTION FOR INJECTION OR INFUSION IN PRE-FILLED SYRINGE 48 MU/0.5ML AND 30 MU/0.5ML,Filgrastim,NDA-2/3,ACCORD HEALTHCARE PRIVATE LIMITED,08/07/2021,SIN16267P and SIN16268P
VYZULTA (LATANOPROSTENE BUNOD) OPHTHALMIC SOLUTION 0.024%,Latanoprostene Bunod,NDA-1: New chemical entity,Bausch & Lomb (Singapore) Private Limited,01/06/2021,SIN16214P
"RYBELSUS TABLET 3MG, 7MG AND 14MG",Semaglutide,NDA-1: New chemical entityNDA-3: New strength,NOVO NORDISK PHARMA (SINGAPORE) PTE LTD,01/06/2021,"SIN16251P, SIN16216P, SIN16217P"
"IMBRUVICA FILM-COATED TABLETS 140MG, 280MG, 420MG, 560MG",Ibrutinib,NDA-2: New dosage formNDA-3: New strength,JOHNSON & JOHNSON PTE. LTD.,03/06/2021,"SIN16218P, SIN16219P, SIN16220P, SIN16221P"
MYLOTARG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/ VIAL,Gemtuzumab ozogamicin,NDA-1: New biological entity,PFIZER PRIVATE LIMITED,21/06/2021,SIN16243P
PELGRAZ SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE 6MG/0.6ML,Pegfilgrastim,NDA-2: Biosimilar,ACCORD HEALTHCARE PRIVATE LIMITED,24/06/2021,SIN16249P
"PHESGO SOLUTION FOR INJECTION 1200 MG/600 MG/15 ML, 600 MG/600 MG/10 ML","Pertuzumab, Trastuzumab",NDA-2: New combination/dosing regimenNDA-3: New strength,ROCHE SINGAPORE PTE. LTD.,22/06/2021,"SIN16247P, SIN16248P"
REPLAGAL CONCENTRATE FOR SOLUTION FOR INFUSION 1 MG/ML,Agalsidase alfa,NDA-1: New biological entity,TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.,17/05/2021,SIN16197P
"APROVASC FILM COATED TABLET 150MG/5MG, 300MG/5MG, 300MG/10MG","Irbesartan, amlodipine besilate",NDA-2: New combination,SANOFI-AVENTIS SINGAPORE PTE. LTD.,14/05/2021,"SIN16194P, SIN16195P, SIN16196P"
REMLEAS HARD CAPSULES 40MG,Valbenazine ditosylate 73mg eqv valbenazine 40mg,NDA-1: New chemical entity,MITSUBISHI TANABE PHARMA SINGAPORE PTE LTD,19/5/2021,SIN16198P
KANJINTI POWDER FOR INJECTION 150MG/VIAL AND 440MG/VIAL,Trastuzumab,NDA-2: BiosimilarNDA-3: New strength,AMGEN BIOTECHNOLOGY SINGAPORE PTE LTD,25/5/2021,"SIN16206P, SIN16207P"
EVENITY SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 105 MG/1.17 ML,Romosozumab,NDA-1: New chemical entity,AMGEN BIOTECHNOLOGY SINGAPORE PTE LTD,27/5/2021,SIN16208P
"CRYSVITA® SOLUTION FOR INJECTION 10MG/ML, 20MG/ML, 30MG/ML",Burosumab,"NDA-1: New chemical entity, NDA-3: New strengths",Kyowa Kirin Asia Pacific Pte Ltd,3/5/2021,"SIN16176P, SIN16177P, SIN16178P"
"VERASEAL SOLUTION FOR SEALANT 80 MG/ML, 500 IU/ML",Human Fibrinogen and Human Thrombin,NDA-2: New dosage form,GRIFOLS ASIA PACIFIC PTE LTD,01/04/2021,SIN16143P
EYBELIS OPHTHALMIC SOLUTION 0.002%,Omidenepag Isopropyl,NDA-1: New chemical entity,SANTEN PHARMACEUTICAL ASIA PTE. LTD.,07/04/2021,SIN16150P
"ATECTURA BREEZHALER INHALATION POWDER, HARD CAPSULE 150 MCG /320 MCGATECTURA BREEZHALER INHALATION POWDER, HARD CAPSULE 150 MCG /160 MCGATECTURA BREEZHALER INHALATION POWDER, HARD CAPSULE 150 MCG /80 MCG",Indacaterol/Mometasone furoate,NDA-2/3: New combination/New strength,NOVARTIS (SINGAPORE) PTE LTD,07/04/2021,SIN16147PSIN16148PSIN16149P
"ENERZAIR BREEZHALER INHALATION POWDER, HARD CAPSULE 150 MCG /50 MCG /160 MCG",Indacaterol/ Glycopyrronium/ Mometasone furoate,NDA-2: New combination,NOVARTIS (SINGAPORE) PTE LTD,14/04/2021,SIN16153P
"OZEMPIC SOLUTION FOR INJECTION IN PRE-FILLED PEN 1 MG/DOSE, 0.25 MG, 0.5 G/DOSE",Semaglutide,NDA-1: New Biological Entity,NOVO NORDISK PHARMA (SINGAPORE) PTE LTD,21/04/2021,"SIN16164P, SIN16165P"
"CRYSVITA® SOLUTION FOR INJECTION 10MG/ML, 20MG/ML, 30MG/ML",Burosumab,"NDA-1/3: New Biological Entity, New Strengths",KYOWA KIRIN ASIA PACIFIC PTE LTD,30/04/2021,"SIN16176P, SIN16177P, SIN16178P"
MVASI CONCENTRATE FOR SOLUTION FOR INFUSION 25MG/ML,Bevacizumab,NDA-2: Biosimilar,AMGEN BIOTECHNOLOGY SINGAPORE PTE LTD,10/04/2021,SIN16151P
Nucala Solution for Injection in Pre-filled Syringe 100mg/mLNucala Solution for Injection in Pre-filled Pen 100mg/mL,Mepolizumab,NDA-2: New presentation,GlaxoSmithKline Pte Ltd,27/04/2021,"SIN16171P, SIN16172P"
"NOVOEIGHT POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 250IU/VIAL, 500IU/VIAL AND 1000IU/VIAL",Turoctocog Alfa,NDA-1: New biological entityNDA-3: New strength,NOVO NORDISK PHARMA (SINGAPORE) PTE LTD,01/03/2021,"SIN16109P, SIN16110P, SIN16111P"
XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 75MG/0.5ML AND 150MG/1.0ML,Omalizumab,NDA-2: New dosage formNDA-3: New strength,NOVARTIS (SINGAPORE) PTE LTD,04/03/2021,SIN16115P and SIN16116P
ANSTO-SODIUM IODIDE [131I] THERAPY CAPSULE VIAL (50 MBQ TO 6000 MBQ),Sodium Iodide [I-131] 50 to 6000 MBq,NDA-2: New strength,Transmedic Pte Ltd,08/03/2021,SIN16117P
SIMPONI SOLUTION FOR INJECTION IN PRE-FILLED PEN 45MG/0.45ML,Golimumab,NDA-2: New strength,Johnson & Johnson Pte. Ltd.,09/03/2021,SIN16118P
ABILIFY TABLET 2MGABILIFY ORAL SOLUTION 1MG/ML,Aripiprazole,NDA-2: New strengthNDA-2: New dosage form,OTSUKA PHARMACEUTICALS (SINGAPORE) PTE. LTD.,10/03/2021,SIN16119PSIN16120P
DUPIXENT SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE 200 mg/1.14ml,Dupilumab,"NDA-2: New strength, new indication and dosing regimen",SANOFI-AVENTIS SINGAPORE PTE. LTD.,15 Mar 2021,SIN16121P
PANADOL CHILDREN SUSPENSION 250MG/5ML,Paracetamol,NDA-2: New dosage form,GSK CONSUMER HEALTHCARE SINGAPORE PTE. LTD.,30/03/2021,SIN16142P
SMOFKABIVEN EXTRA NITROGEN EMULSION FOR INFUSIONSMOFKABIVEN EXTRA NITROGEN ELECTROLYTE-FREE EMULSION FOR INFUSION,SMOFLipid 20% (SIN13246P)Amino acids ± electrolytesGlucose,NDA-2: New strength,Fresenius Kabi (Singapore) Pte Ltd,24 Mar 2021,SIN16135PSIN16136P
KESIMPTA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 20MG/0.4MLKESIMPTA SOLUTION FOR INJECTION IN PRE-FILLED PEN 20MG/0.4ML,Ofatumumab,NDA-1: New biological entityNDA-2: New strength,NOVARTIS (SINGAPORE) PTE LTD,05/02/2021,"SIN16100P, SIN16101P"
NUBEQA FILM-COATED TABLET 300MG,Darolutamide milled,NDA-1: New chemical entity,BAYER (SOUTH EAST ASIA) PTE LTD,11/02/2021,SIN16103P
GENTECH MOLYBDENUM (99Mo) / TECHNETIUM (99mTc) STERILE GENERATOR,Sodium pertechnetate (99mTc),NDA-2: New dosage form/indication,TRANSMEDIC PTE LTD,24/02/2021,SIN16108P
VPRIV POWDER FOR SOLUTION FOR INFUSION 400UNITS/VIAL,Velaglucerase alfa,NDA-1: New Chemical Entity,Takeda Pharmaceuticals (Asia Pacific) Pte Ltd,24/02/2021,SIN16107P
SONAZOID POWDER AND SOLVENT FOR DISPERSION FOR INJECTION 16 MICROLITRE PER VIAL,Perfluorobutane (microbubbles),NDA-1,GE HEALTHCARE PTE. LTD.,06/01/2021,SIN16077P
SHINGRIX POWDER AND SUSPENSION FOR SUSPENSION FOR INJECTION 50MCG/0.5ML,[Antigen] Recombinant Varicella Zoster Virus glycoprotein E (gE),NDA-1,GLAXOSMITHKLINE PTE LTD,12/01/2021,SIN16079P
IDACIO SOLUTION FOR INJECTION IN PRE-FILLED PEN 40MG/0.8MLIDACIO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 40MG/0.8MLIDACIO SOLUTION FOR INJECTION FOR PAEDIATRIC USE 40MG/0.8ML VIAL,Adalimumab,NDA-2,FRESENIUS KABI (SINGAPORE) PTE LTD,25/01/2021,SIN16083PSIN16084PSIN16085P
ROZLYTREK HARD CAPSULES 100MG AND 200MG,Entrectinib,"NDA-1,3",ROCHE SINGAPORE PTE LTD,27/01/2021,"SIN16086P, SIN16087P"
XOSPATA® FILM-COATED TABLETS 40 MG,Gilteritinib,NDA-1,ASTELLAS PHARMA SINGAPORE PTE. LTD.,28/01/2021,SIN16088P
CLARITYN SYRUP 5 MG/5 ML (GRAPE FLAVOR),Loratadine,NDA-2,BAYER (SOUTH EAST ASIA) PTE LTD,29/1/2021,SIN16091P
"LIXIANA FILM-COATED TABLET 15MG, 30MG AND 60MG",Edoxaban Tosilate,NDA-1: New chemical/biological entityNDA-3: New strength,A.MENARINI SINGAPORE PTE LTD,18/12/2020,"SIN16059P, SIN16060P, SIN16061P"
NALDEBAIN EXTENDED RELEASE INJECTION 75 MG/ML,Dinalbuphine sebacate,NDA-1: New chemical entity,INTEGA PTE LTD,15/12/2020,SIN16058P
EMGALITY SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 100MG/ML,Galcanezumab,NDA-2: New presentation/indication/strength,Eli Lilly (Singapore) Pte Ltd,18 Dec 20,SIN16063P
REMSIMA SOLUTION FOR SUBCUTANEOUS INJECTION 120MG/ML IN PRE-FILLED SYRINGEREMSIMA SOLUTION FOR SUBCUTANEOUS INJECTION 120MG/ML IN PRE=FILLED PEN,Infliximab,NDA-2: New presentation and new route of administration,CELLTRION HEALTHCARE SINGAPORE PRIVATE LIMITED,29/12/2020,"SIN16069P, SIN16070P"
MAYZENT FILM-COATED TABLETS 0.25MG AND 2MG,Siponimod,NDA-1: New chemical entity,Novartis (Singapore) Pte Ltd,16 Nov 2020,"SIN16039P, SIN16040P"
FASENRA SOLUTION FOR INJECTION 30MG/ML (AUTOINJECTOR PEN),Benralizumab,NDA-2: New dosage form,ASTRAZENECA SINGAPORE PTE LTD,18/11/2020,SIN16043P
ADYNOVATE POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 250IU/ 500IU/ 1000IU/ 1500IU/ 2000IU/ 3000IU,"Rurioctocog alfa pegol [Antihemophilic Factor (Recombinant), PEGylated]",NDA-1 and NDA-3: New biological entity and new strength,Takeda Pharmaceuticals (Asia Pacific) Pte. Ltd.,24 Nov 2020,"SIN16048P, SIN16049P, SIN16050P, SIN16051P, SIN16052P, SIN16053P"
TRAZIMERA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 440MG,Trastuzumab,NDA-2,Pfizer Private Limited,11 Nov 2020,SIN16038P
PECFENT NASAL SPRAY SOLUTION 100MCG/SPRAYPECFENT NASAL SPRAY SOLUTION 400MCG/SPRAY,Fentanyl,NDA-2: New dosage form,A.MENARINI SINGAPORE PTE. LTD.,12/10/2020,"SIN16026P, SIN16027P"
XYZAL FILM-COATED TABLET 5 MG,Levocetirizine dihydrochloride (5 mg),NDA-2*: New forensic classification of the 50's pack size (Split license from SIN12084P),GlaxoSmithKline Pte. Ltd.,14/10/2020,SIN16028P
DARZALEX SC SOLUTION FOR INJECTION 1800MG/15ML,Daratumumab,NDA-2: New dosage form,JOHNSON & JOHNSON PTE LTD,27/10/2020,SIN16032P
SPRAVATO NASAL SPRAY 28 MG/VIAL,Esketamine,NDA-1,Johnson & Johnson Pte Ltd,27 Oct 2020,SIN16033P
POLIVY POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 140MG,Polatuzumab vedotin,NDA-1: New biological entity,ROCHE SINGAPORE PTE LTD,08/09/2020,SIN16007P
SEMGLEE SOLUTION FOR INJECTION IN A PREFILLED PEN 100U/ML,Insulin glargine,NDA-2: Biosimilar,MYLAN PHARMACEUTICALS PTE. LTD.,14/09/2020,SIN16009P
FULPHILA SOLUTION FOR INJECTION 6MG/0.6ML,Pegfilgrastim,NDA-2: Biosimilar,MYLAN PHARMACEUTICALS PTE. LTD.,21/09/2020,SIN16012P
ODEFSEY FILM COATED TABLET 200MG/25MG/25MG,Emtricitabine / Rilpivirine hydrochloride / Tenofovir alafenamide fumarate,NDA-2: New combination,JOHNSON & JOHNSON PTE LTD,24/09/2020,SIN16015P
LONQUEX PRE-FILLED SYRINGE 6MG/0.6ML,Lipegfilgrastim,NDA-1,Drug Houses of Australia Pte Ltd,25/09/2020,SIN16019P
"BALVERSA FILM-COATED TABLETS 3MG, 4MG, 5MG",Erdafitinib,NDA-1/3,JOHNSON & JOHNSON PTE. LTD.,07/08/2020,"SIN15986P, SIN15987P, SIN15988P"
DOVATO FILM-COATED TABLET 50MG/ 300MG,"Dolutegravir, Lamivudine",NDA-2,GLAXOSMITHKLINE PTE LTD,13/08/2020,SIN15989P
VITRAKVI HARD CAPSULE 100MG AND 25MGVITRAKVI ORAL SOLUTION 20MG/ML,Larotrectinib,NDA-1/2/3,BAYER (SOUTH EAST ASIA) PTE LTD,17/08/2020,"SIN15991P, SIN15992P, SIN15993P"
FIASP FLEXTOUCH 100U/MLFIASP SOLUTION FOR INJECTION IN VIAL 100U/ML,Insulin Aspart,NDA-2,NOVO NORDISK PHARMA (SINGAPORE) PTE LTD,17/08/2020,"SIN15994P, SIN15995P"
LYSAKARE SOLUTION FOR INFUSION 25G / 25G,"L-Arginine Hydrochloride, L-Lysine Hydrochloride",NDA-2: New combination,NOVARTIS (SINGAPORE) PTE LTD,31/08/2020,SIN16003P
ENDOLUCINBETA RADIOPHARMACEUTICAL PRECURSOR SOLUTION 40 GBQ/ML,Lutetium (177Lu) chloride,NDA-1: New chemical entity,QT INSTRUMENTS (S) PTE LTD,03/07/2020,SIN15971P
SKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 75MG,Risankizumab,NDA-1: New chemical entity,ABBVIE PTE LTD,06/07/2020,SIN15972P
"FENTORA® BUCCAL TABLETS 100MCG, 200MCG, 400MCG, 600MCG AND 800MCG",Fentanyl Citrate,NDA-2: New dosage formNDA-3: Subsequent new strengths,DRUG HOUSES OF AUSTRALIA PTE LTD,28 July 2020,"SIN15977P, SIN15978P, SIN15979P, SIN15980P, SIN15981P"
LUTATHERA SOLUTION FOR INFUSION 370 MBQ/ML,Lutetium (177Lu) oxodotreotide,NDA-1: New chemical entity,NOVARTIS (SINGAPORE) PTE LTD,01/06/2020,SIN15947P
IXIFI POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL,Infliximab,NDA-2,PFIZER PRIVATE LIMITED,03/06/2020,SIN15948P
VEKLURY LYOPHILIZED POWDER FOR IV INFUSION 100MG/VIALVEKLURY SOLUTION FOR IV INFUSION 5MG/ML,Remdesivir,NDA-1/2,GILEAD SCIENCES SINGAPORE PTE LTD,10/06/2020 (Conditional approval),"SIN15950P, SIN15951P"
BASALOG ONE SOLUTION FOR INJECTION IN A PRE-FILLED PEN 100 IU/ML,Insulin glargine,NDA-2,DUOPHARMA (SINGAPORE) PTE LTD,12/06/2020,SIN15954P
RINVOQ EXTENDED RELEASE TABLETS 15MG,Upadacitinib,NDA-1,Abbvie Pte. Ltd.,16/06/2020,SIN15959P
"LOKELMA POWDER FOR ORAL SUSPENSION 5G, 10G",Sodium zirconium cyclosilicate,NDA-1/3,ASTRAZENECA SINGAPORE PTE LTD,22/06/2020,"SIN15961P, SIN15962P"
BILAXTEN ORAL SOLUTION 2.5MG/ML,Bilastine,NDA-2,A Menarini Singapore Pte Ltd,24/06/2020,SIN15963P
TECENTRIQ CONCENTRATE FOR SOLUTION FORINFUSION 840MG/14ML,Atezolizumab,NDA-2,ROCHE SINGAPORE PTE. LTD.,25 June 2020,SIN15964P
VIZIMPRO FILM-COATED TABLET 15MGVIZIMPRO FILM-COATED TABLET 30MGVIZIMPRO FILM-COATED TABLET 45MG,Dacomitinib monohydrate,NDA-1/3: New chemical entity,Pfizer Private Limited,25/06/2020,"SIN15965P, SIN15966P, SIN15967P"
RIXATHON CONCENTRATE FOR SOLUTION FOR INFUSION 500MG/50MLRIXATHONG CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML,Rituxiamb,NDA-2/3: New biosimilar,Novartis (Singapore) Pte Ltd,30/06/2020,"SIN15969P, SIN15970P"
AJOVY SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 225MG/1.5ML,FREMANEZUMAB,NDA-1: New biological entity,DRUG HOUSES OF AUSTRALIA PTE LTD,08 MAY 2020,SIN15937P
TUKYSA FILM-COATED TABLETS 50 MG AND 150 MG,Tucatinib,NDA-1: New chemical entity,NYPRAX PHARMA PTE. LTD.,19/05/2020,"SIN15942P, SIN15943P"
TALZENNA CAPSULE 0.25MG AND 1MG,Talazoparib tosylate,NDA-1: New chemical entityNDA-3: New strength,PFIZER PRIVATE LIMITED,22/05/2020,"SIN15944P, SIN15945P"
"NUWIQ POWDER AND SOLVENT FOR INJECTION 250IU, 500IU, 1000IU, 2000IU",SIMOCTOCOG ALFA,NDA-2: New dosage formNDA-3: New strength,WELLCHEM PHARMACEUTICALS PTE LTD,01/04/2020,"SIN15920P, SIN15921P, SIN15922P, SIN15923P"
TRIMBOW PRESSURISED INHALATION SOLUTION 100/6/12.5 ?g PER ACTUATION,"Beclometasone dipropionate anhydrous 0.1mg/actuation, Formoterol fumarate dehydrate 0.006mg/actuation, Glycopyrronium bromide 0.0125mg/actuation",NDA-2: New combination,ORIENT EUROPHARMA PTE LTD,02/04/2020,SIN15924P
AIMOVIG SOLUTION FOR INJECTION FOR PRE-FILLED PEN 140MG/MLAIMOVIG SOLUTION FOR INJECTION FOR PRE-FILLED SYRINGE 140MG/ML,Erenumab,NDA-3: New strength,Novartis (Singapore) Pte Ltd,03/04/2020,"SIN15925P, SIN15926P"
XERAVA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG PER VIAL,Eravacycline,NDA-1: New drug,Everest Medicines (Singapore) Pte Ltd,15/04/2020,SIN15930P
SAMSCA TABLET 15MG,Tolvaptan,NDA-1:New Drug,Otsuka Pharmaceuticals (Singapore) Pte Ltd,24/04/2020,SIN15934P
ISENTRESS HD FILM COATED TABLET 600MG,Raltegravir,NDA-2: New strength,MSD Pharma (Singapore) Pte. Ltd.,27/04/2020,SIN15935P
PHENYLALPHA SOLUTION FOR INJECTION 50MCG/ML,Phenylephrine hydrochloride,NDA-2: New dosage form,INTEGA PTE LTD,03/03/2020,SIN15896P
CALIBERI ORODISPERSIBLE FILM 20MGCALIBERI ORODISPERSIBLE FILM 5MG,Tadalafil,NDA-2: New dosage formNDA-3: New strength,ABBOTT LABORATORIES (SINGAPORE) PRIVATE LIMITED,09/03/2020,"SIN15898P,SIN15899P"
STEGLATRO FILM-COATED TABLETS 5MGSTEGLATRO FILM-COATED TABLETS 15MG,Ertugliflozin L-PGA,NDA-1: New chemical entityNDA-3: New strength,MSD PHARMA (SINGAPORE) PTE. LTD.,11/03/2020,"SIN15901P, SIN15902P"
STEGLUJAN FILM-COATED TABLETS 5MG/100MGSTEGLUJAN FILM-COATED TABLETS 15MG/100 MG,Sitagliptin phosphate monohydrate / ertugliflozin L-PGA,NDA-2: New combinationNDA-3: New strength,MSD PHARMA (SINGAPORE) PTE. LTD.,11/03/2020,"SIN15904P, SIN15905P"
DELSTRIGO FILM COATED TABLET,"Lamivudine 100mg, Tenofovir disoproxil fumarate 300mg, Doravirine 100mg",NDA-2: New combination,MSD PHARMA (SINGAPORE) PRIVATE LIMITED,13 Mar 2020,SIN15909P
HUMIRA SOLUTION FOR INJECTION 80 MG/0.8ML (PREFILLED PEN)HUMIRA SOLUTION FOR INJECTION 80 MG/0.8ML (PREFILLED SYRINGE),Adalimumab,NDA-2: New strength,ABBVIE PTE. LTD.,19/03/2020,"SIN15914P, SIN15915P"
"PIQRAY 250, 300 AND 200MG DAILY DOSE PACKS",Alpelisib,NDA-1 (250MG): New chemical entityNDA-3: Subsequent strengths,NOVARTIS (SINGAPORE) PTE LTD,25/03/2020,"SIN15916P, SIN15917P and SIN15918P"
EMGALITY SOLUTION FOR INJECTION IN PRE-FILLED PEN 120MG/ML,Galcanezumab,NDA-1: New chemical entity,Eli Lilly (Singapore) Pte Ltd,25/03/2020,SIN15919P
"ALBURX SOLUTION FOR INFUSION 5%, 20%, 25%",Human albumin,NDA-2: New dosage formNDA-3: Subsequent strengths,CSL Behring Pte Ltd,11/03/2020,"SIN15903P, SIN15906P and SIN15907P"
SPIRIVA RESPIMAT RE-USABLE SOLUTION FOR INHALATION 2.5 MICROGRAM,Tiotropium,NDA-2: New presentation,BOEHRINGER INGELHEIM SINGAPORE PTE. LTD.,18/02/2020,SIN15885P
GLANATEC OPHTHALMIC SOLUTION 0.4% W/V,Ripasudil Hydrochloride Hydrate,NDA-1: New chemical entity,DKSH Singapore Ptd Ltd,18/02/2020,SIN15886P
BOOSTRIX POLIO SUSPENSION FOR INJECTION,"TETANUS TOXOID(20 iu/0.5 ml),DIPHTHERIA TOXOID(2 iu/0.5 ml),PERTACTIN(2.5 mcg/0.5 ml), FILAMENTOUS HAEMAGGLUTININ(8 mcg/0.5 ml),PERTUSSIS TOXOID(8mcg/0.5ml)",NDA-2,GLAXOSMITHKLINE PTE LTD,20/02/2020,SIN15888P
SPIOLTO RESPIMAT RE-USABLE SOLUTION FOR INHALATION 2.5 MICROGRAM / 2.5 MICROGRAM,Tiotropium / Olodaterol,NDA-2: New presentation,BOEHRINGER INGELHEIM SINGAPORE PTE. LTD.,25/01/2020,SIN15890P
ENSTILAR CUTANEOUS FORM,Betamethasone dipropionate 0.5mg/g and Calcipotriol 50mcg/g,NDA-2: New presentation,Leo Pharma AsiaPtd Ltd,27/02/2020,SIN15892P
"VYNDAQEL SOFT GELATIN CAPSULE 20 MG,VYNDAMAX SOFT GELATIN CAPSULE 61 MG","Tafamidis meglumine (for Vyndaqel),Tafamidis (for Vyndamax)","NDA-1: New chemical entity, NDA-2: New dosage form",Pfizer Private Limited,27/02/2020,SIN15893P. SIN15894P
HAEMOCOMPLETTAN P POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1G/VIAL,Human Fibrinogen,"NDA-1: New chemical entity, NDA-2: New dosage form",CSL Behring Pte Ltd,28/02/2020,SIN15895P
BILAXTEN ORODISPERSIBLE TABLET 10MG,Bilastine,NDA-2: New dosage form,A. MENARINI SINGAPORE PTE. LTD.,13/01/2020,SIN15874P
VASTAREL XR EXTENDED-RELEASE HARD CAPSULE 80 MG,Trimetazidine,NDA-2: New dosage form,SERVIER (S) PTE LTD,20/01/2020,SIN15877P
"SPEDRA TABLET 50MG, 100MG, 200MG",Avafanil,NDA-1/3: New chemical entity/New strength,A.Menarini Singapore Pte Ltd,24/01/2020,"SIN15879P, SIN15880P, SIN15881P"
RAPAMUNE TABLET 0.5 MG,Sirolimus,NDA-3: New strength,PFIZER PRIVATE LIMITED,20/01/2020,SIN15878P
PIFELTRO FILM COATED TABLETS 100MG,Doravirine,NDA-1: New chemical entity,MSD PHARMA (SINGAPORE) PTE. LTD.,012/12/2019,SIN15869P
ZAVICEFTA POWDER FOR CONCENTRATE FOR SOLUION FOR INFUSION 2G/0.5G,"Avibactam sodium, Ceftazidime pentahydrate",NDA-1: New chemical entity,PFIZER PRIVATE LIMITED,12/12/2019,SIN 15870P
"VYVANSE CAPSULES 20MG, 30MG, 40MG, 50MG, 60MG and 70MG",Lisdexamfetamine dimesylate,"NDA-1: New chemical entity, NDA-3: New strength",SHIRE SINGAPORE PTE LTD,01/11/2019,"SIN15840P, SIN15841P, SIN15842P, SIN15843P, SIN15844P and SIN15845P"
"LIVALO FILM COATED TABLETS 2MG, 4MG",Pitavastatin,"NDA-1: New chemical entity, NDA-3: New strength",DKSH SINGAPORE PTE LTD,22/11/2019,"SIN15859P, SIN15860P"
OGIVRI LYOPHILIZED POWDER FOR INJECTION440MG PER VIAL,Trastuzumab,NDA-2: Biosimilar,MYLAN PHARMACEUTICALS PTE.LTD .,04/11/2019,SIN15850P
MONOFER SOLUTION FOR INJECTION OR INFUSION 100 MG/ML,Ferric Derisomaltose 417 mg/ml (Elementary Iron 100 mg/ml),NDA-1: New chemical entity,COMPAI PHARMA PTE LTD,14/11/2019,SIN15855P
NERLYNX FILM-COATED TABLETS 40 MG,Neratinib maleate,NDA-1: New chemical entity,SPECIALISED THERAPEUTICS ASIA PTE LTD,25/11/2019,SIN15861P
"ERDOMED HARD CAPSULES 300MG, ERDOMED DISPERSIBLE TABLETS 300MG",Erdosteine,NDA-1: New chemical entityNDA-2: New dosage form,HYPHENS PHARMA PTE. LTD.,02/10/2019,"SIN15825P, SIN15826P"
FIBRYGA POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1G/VIAL,Human Fibrinogen,NDA-2,WELLCHEM PHARMACEUTICALS PTE LTD,16/10/2019,SIN15829P
LORVIQUA FILM-COATED TABLET 25 AND 100MG,Lorlatinib,NDA-1: New chemical entityNDA-3: New strength,PFIZER PRIVATE LIMITED,16/10/2019,SIN15830PSIN15831P
TASIGNA  CAPSULE 50MG,Nilotinib,NDA-2,NOVARTIS (SINGAPORE) PTE LTD,23/10/2019,SIN15837P
HERZUMA™ 440MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION; HERZUMA™ 150MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION,Trastuzumab,NDA-2: BiosimilarNDA-3: New strength,CELLTRION HEALTHCARE SINGAPORE PRIVATE LIMITED,29/10/2019,"SIN15838P, SIN15839P"
PRIFTIN FILM-COATED TABLET 150 MG,Rifapentine,NDA-1: New chemical entity,SANOFI-AVENTIS SINGAPORE PTE. LTD.,02/09/2019,SIN15793P
VOKANAMET FILM-COATED TABLETS 50 MG/500 MGVOKANAMET FILM-COATED TABLETS 50 MG/1000 MGVOKANAMET FILM-COATED TABLETS 150 MG/500 MGVOKANAMET FILM-COATED TABLETS 150 MG/1000 MG,Canagliflozin and Metformin,NDA-2: New combination,JOHNSON & JOHNSON PTE. LTD,05/09/2019,SIN15797PSIN15798PSIN15799PSIN15800P
PANVAX PANDEMIC INFLUENZA VACCINE (ADJUVANTED)10ML SUSPENSION FOR INJECTION VIAL,"Pandemic Influenza Virus Type A, inactivated and disrupted",NDA-1: New chemical entity,SEQIRUS PTE LTD .,06/09/2019,SIN15801P
TRELEGY ELLIPTA INHALATION POWDER 100MCG/62.5MCG/25MCG,Fluticasone furoate (micronized)Umeclidinium bromide (micronized)Vilanterol trifenatate (micronized),NDA-2: New combination,GLAXOSMITHKLINE PTE. LTD.,12/09/2019,SIN15806P
IDELVION POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 250IU/VIALIDELVION POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 500IU/VIALIDELVION POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 1000IU/VIALIDELVION POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 2000IU/VIAL,Albutrepenonacog alfa,NDA-1: New biological entityNDA-3: New strength,CSL BEHRING PTE. LTD,19/09/2019,SIN15811PSIN15812PSIN15813PSIN15814P
KANARB®PLUS FILM COATED TABLETS 60 MG/12.5 MGKANARB®PLUS FILM COATED TABLETS 120 MG/12.5 MG,"Fimasartan, Hydrochlorothiazide",NDA-2: New combinationNDA-3: New strength,Zuellig Pharma Pte Ltd,26/09/2019,"SIN15818P, SIN15819P"
AFSTYLA POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 250IU/VIALAFSTYLA POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 500IU/VIALAFSTYLA POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 1000IU/VIALAFSTYLA POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 2000IU/VIALAFSTYLA POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 3000IU/VIAL,Lonoctocog alfa,NDA-1: New biological entityNDA-3: New strength,CSL BEHRING PTE. LTD.,27/09/2019,"SIN15821P, SIN15822P, SIN15823P, SIN15824P, SIN15820P"
ENGERIX-B SUSPENSION FOR INJECTION IN PREFILLED SYRING 10MCG/0.5MLENGERIX-B SUSPENSION FOR INJECTION IN PREFILLED SYRING 20MCG/1ML,Hepatitis B Surface antigen,NDA-2: New presentation,GlaxoSmithKline Pte Ltd,13/09/2019,"SIN15808P, SIN15807P"
GILENYA CAPSULE 0.25MG,Fingolimod,NDA-2: New strength / indication / dosing regimen,NOVARTIS (SINGAPORE) PTE LTD,05/08/2019,SIN15761P
"REXULTI FILM-COATED TABLETS 4MG, 3MG, 2MG, 1MG, 0.5MG AND 0.25MG",Brexpiprazole,NDA-1: New chemical entityNDA-3: New strengths,LUNDBECK SINGAPORE PTE. LTD.,05/08/2019,"SIN15763P, SIN15764P, SIN15765P, SIN15766P, SIN15767, SIN15768P"
"BERIATE POWDER AND SOLVENT FOR SOLUTION FOR INJECTION OR INFUSION 250IU/VIAL, 500IU/VIAL",Human coagulation factor VIII,NDA-2: Others (Factor VIII product),CSL Behring Pte Ltd,07/08/2019,"SIN15771P, SIN15772P"
SKYCELLFLU QUADRIVALENT PREFILLED SYRINGE,"Purified inactivated influenza virus surface antigen [A/Christchurch/16/2010, NIB-74xp (H1N1)]Purified inactivated influenza virus surface antigen [A/HongKong/4801/2014, NYMC X263 (H3N2)]Purified inactivated influenza virus surface antigen [B/Brisbane/60/2008, NYMC BX-35]Purified inactivated influenza virus surface antigen [B/Phuket/3073/2013]",NDA-2: New combination,AJ BIOLOGICS PTE. LTD.,16/08/2019,SIN15781P
"VERZENIO FILM-COATED TABLET 50MG, 100MG AND 150MG",Abemaciclib,NDA-1: New chemical entityNDA-3: New strength,ELI LILLY (SINGAPORE) PTE LTD,26/08/2019,"SIN15788P, SIN15789P, SIN15790P"
AMGEVITA SOLUTION FOR INJECTION IN PREFILLED SYRINGE 40MG/0.8MLAMGEVITA SOLUTION FOR INJECTION IN PREFILLED SYRINGE 20MG/0.4MLAMGEVITA SOLUTION FOR INJECTION IN PREFILLED AUTOINJECTOR 40MG/0.8ML,Adalimumab,NDA-2/3: Biosimilar,AMGEN SINGAPORE MANUFACTURING PTE. LTD.,PFS: 02/07/2019PF autoinjector: 31/07/2019,"SIN15731P, SIN15732P; SIN15760P"
KEVZARA SOLUTION FOR INJECTION IN PRE-FILLED PEN 150MG AND 200MG,Sarilumab,NDA-2: New dosage formNDA-3: New strength,SANOFI-AVENTIS SINGAPORE PTE LTD,08/07/2019,SIN15737P and SIN15738P
TEKCIS RADIONUCLIDE GENERATOR 2-50GBQ,Sodium molybdate,NDA-2,QT INSTRUMENT (S) PTE LTD,10/07/2019,SIN15741P
"SYMVENU® HARD CAPSULES 1.5MG, 3MG, 4.5MG, 6MG",Cariprazine,NDA-1: New chemical entityNDA-3: New strength,MITSUBISHI TANABE PHARMA SINGAPORE PTE LTD,11/07/2019,"SIN15743P, SIN15744P, SIN15745P, SIN15746P"
BESPONSA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1MG/VIAL,Inotuzumab Ozogamicin,NDA-1,PFIZER PRIVATE LIMITED,17/07/2019,SIN15747P
BAT STERILE SOLUTION FOR INJECTION,"Botulism antitoxin (equine) serotypes A, B, C, D, E, F, G",NDA-1,EMERGENT SALES AND MARKETING SINGAPORE PTE LTD,18/07/2019,SIN15749P
CALQUENCE HARD CAPSULES 100MG,Acalabrutinib,NDA-1: New chemical entity,ASTRAZENECA SINGAPORE PTE LTD,25/07/2019,SIN15753P
"PREVYMIS FILM COATED TABLET 240MG, 480MGPREVYMIS CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML",Letermovir,NDA 1/2/3,MSD PHARMA (SINGAPORE) PTE LTD,30/07/2019,"SIN15757P, SIN15758P, SIN15759P"
CRESEMBA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 200MG/ CRESEMBA CAPSULES 100MG,Isavuconazonium sulfate,NDA-1/ NDA-2,PFIZER PRIVATE LIMITED,13/06/2019,SIN15717P/ SIN15716P
HUMIRA SOLUTION FOR INJECTION 20MG/0.2ML (PRE-FILLED SYRINGE),Adalimumab,NDA-2: New strength / dosing regimen,ABBVIE PTE LTD,17/06/2019,SIN15718P
FUCICORT LIPID CREAM,"Betamethasone valerate, Fusidic acid",NDA-2: New dosage form,LEO PHARMA ASIA PTE LTD,18/06/2019,SIN15720P
PHOXILIUM SOLUTION FOR HAEMODIALYSIS/ HAEMOFILTRATION,Disodium Phosphate Dihydrate + Potassium Chloride + Sodium Chloride + Sodium Hydrogen Carbonate + Magnesium Chloride Hexahydrate + Calcium Chloride Dihydrate,NDA-2: New combination,BAXTER HEALTHCARE (ASIA) PTE LTD,27/06/2019,SIN15730P
"PERGOVERIS SOLUTION FOR INJECTION IN PRE-FILLED PEN (300IU+150IU)/0.48ML, (450IU+ 225 IU)/0.72ML, (900IU + 450IU)/1.44ML","Follitropin alfa (r-hFSH), Lutropin alfa (r-LH)",NDA-2: New dosage formNDA-3: New strength,MERCK PTE LTD,11/06/2019,"SIN15711P, SIN15712P, SIN15713P"
XOFLUZA TABLETS 20MG AND 40MG,Baloxavir marboxil,NDA-1: New chemical entity,ROCHE SINGAPORE PTE LTD,03/05/2019,SIN15679P and SIN15680P
FASENRA SOLUTION FOR INJECTION 30MG/ML (PRE FILLED SYRINGE),Benralizumab,NDA-1: New biological entity,ASTRAZENECA SINGAPORE PTE LTD,09/05/2019,SIN15683P
KEVZARA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150 AND 200MG,Sarilumab,NDA-1: New biological entityNDA-3: New strength,SANOFI-AVENTIS SINGAPORE PTE LTD,09/05/2019,SIN15681P and SIN15682P
NEURONOX LYOPHILLISED POWDER FOR INJECTION 100 UNITS/VIAL,Clostridium botulinum toxin type A,NDA-2,FONDACO PTE LTD,24/05/2019,SIN15692P
MAVENCLAD TABLET 10MG,Cladribine,NDA-1,MERCK PTE. LTD.,24/05/2019,SIN15691P
ERLEADA FILM-COATED TABLET 60MG,Apalutamide,NDA-1,JOHNSON & JOHNSON PTE LTD,27/05/2019,SIN15698P
BETADINE ANTISEPTIC LIQIUD 10% W/V,Povidone-Iodine 10%,NDA-2,MUNDIPHARMA PHARMACEUTICALS PTE LTD,28/05/2019,SIN15699P
PRECEDEX IN 0.9% SODIUM CHLORIDE INJECTION 4MCG/ML,Dexmedetomidine Hydrochloride,NDA-2,PFIZER PTE LTD,22/05/2019,SIN15689P
AIRTAL FILM COATED TABLETS 100mg,Aceclofenac,NDA-1,ZUELLIG PHARMA PTE. LTD.,29/05/2019,SIN15700P
TRESIBA FLEXTOUCH SOLUTION FOR INJECTION IN PRE-FILLED PEN 100 U/MLTRESIBA FLEXTOUCH SOLUTION FOR INJECTION IN PRE-FILLED PEN 200 U/ML,Insulin Degludec,NDA-1/NDA-3,NOVO NORDISK PHARMA (SINGAPORE) PTE LTD,31/05/2019,SIN15703PSIN15704P
RYZODEG® FLEXTOUCH® SOLUTION FOR INJECTION IN PRE-FILLED PEN 100U/ml,Insulin Degludec + Insulin Aspart,NDA-2,NOVO NORDISK PHARMA (SINGAPORE) PTE LTD,31/05/2019,SIN15706P
VOSEVI FILM-COATED TABLETS 400MG/100MG/100MG,Sofosbuvir + Velpatasvir + Voxilaprevir,NDA-1,GILEAD SCIENCES SINGAPORE PTE. LTD,31/05/2019,SIN15705P
"ALUNBRIG FILM-COATED TABLET 30 MG, ALUNBRIG FILM-COATED TABLET 90 MG, ALUNBRIG FILM-COATED TABLET 180 MG, ALUNBRIG INITIATION PACK FILM-COATED TABLET 90 MG & 180 MG",Brigatinib,NDA-1: New chemical entity,TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.,04/04/2019,"SIN15658P, SIN15659P, SIN15660P, SIN15661P"
"LYNPARZA FILM COATED TABLET 100MG, 150MG",Olaparib,NDA-2: New dosage form and NDA-3: New strength,ASTRAZENECA PTE LTD,09/04/2019,"SIN15662P, SIN15663P"
CHOLIB FILM-COATED TABLET 145/20MG,Fenofibrate/Simvastatin,NDA-2: New combination,ABOTT LABORATORIES PTE LTD,09/04/2019,SIN15664P
PHENYLEPHRINE AGUETTANT SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 50MCG/ML,Phenylephrine hydrochloride,NDA-2: New dosage form,INTEGA PTE LTD,15/04/2019,SIN15668P
DAFLON FILM-COATED TABLET 1000 mg,Diosmin/Hesperidin,NDA-3: New strength,SERVIER (S) PTE LTD,16/04/2019,SIN15669P
TRUXIMA CONCENTRATE FOR SOLUTION FOR INFUSION 500MG/50ML,Rituximab,NDA-2: Biosimilar,CELLTRION HEALTHCARE SINGAPORE PRIVATE LIMITED,24/04/2019,SIN15671P
BAVENCIO CONCENTRATE FOR SOLUTION FOR INFUSION 200MG/10ML,Avelumab,NDA-1: New chemical entity,MERCK PTE LTD,25/04/2019,SIN15672P
DUPIXENT SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG / 2ML,Dupilimumab,NDA-1: New chemical entity,SANOFI-AVENTIS SINGAPORE PTE LTD,29/04/2019,SIN15675P
KESTINE FILM-COATED TABLET 20MG,Micronized ebastine,NDA-3: New strength,ZUELLIG PHARMA PTE LTD,12/03/2019,SIN15644P
"TRINOMIA HARD CAPSULES 100MG/20MG/10MG, 100MG/20MG/2.5MG, 100MG/20MG/5MG","Acetysalicylic acid, Atorvastatin, Ramipril","NDA-2: New combination, NDA-3: New strength",DCH AURIGA SINGAPORE,19/03/2019,"SIN15646P, SIN15647P, SIN15648P"
JULUCA FILM-COATED TABLET 50MG/25MG,Dolutegravir / Rilpivirine,NDA-2: New combination,GLAXOSMITHKLINE PTE LTD,22/03/2019,SIN15649P
"REKOVELLE SOLUTION FOR INJECTION IN A PRE-FILLED PEN 12MCG/0.36ML, 36MCG/1.08ML, 72MCG/2.16ML",Follitropin Delta,"NDA-2: New dosage form, NDA-3: New strength",FERRING PHARMACEUTICALS PRIVATE LIMITED,25 MAR 2019,"SIN15650P, SIN15651P, SIN15652P"
"CARIVALAN FILM-COATED TABLET 6.25 MG/5 MG, 6.25 MG/7.5 MG, 12.5 MG/ 5 MG, 12.5 MG/7.5 MG, 25 MG/5 MG, 25 MG/ 7.5 MG","Carvedilol, Ivabradine","NDA-2: New combination, NDA-3: New strength",SERVIER (S) PTE LTD,12/02/2019,"SIN15624P, SIN15625P, SIN15626P, SIN15627P, SIN15628P, SIN15629P"
TRUMENBA SUSPENSION FOR INJECTION IN SINGLE-DOSE PRE-FILLED SYRINGE 0.5ML,"MnB rLP2086 subfamily A, 120?g/ml, MnB rLP2086 subfamily B, 120?g/ml",NDA-1: New biological entity,PFIZER PRIVATE LIMITED,21/02/2019,SIN15634P
BIKTARVY FILM-COATED TABLETS 50/200/25MG,Bictegravir sodium/ emtricitabine/ tenofovir alafenamide fumarate,NDA-1: New chemical entity,GILEAD SCIENCES SINGAPORE PTE LTD,02/01/2019,SIN15604P
"CABOMETYX FILM COATED TABLET 20 MG, 40 MG AND 60 MG",Cabozantinib,NDA-1: New chemical entityNDA-3: New strength,IPSEN PHARMA PTE LTD,03/01/2019,"SIN15606P, SIN15607P, SIN15608P"
PENTASA PROLONGED RELEASE GRANULES 4G/SACHET,Mesalazine,NDA-3: New strength,FERRING PHARMACEUTICALS PTE LTD,18/01/2019,SIN15614P
MINIRIN ORAL LYOPHILISATE 240 MCG,Desmopressin acetate eqv. to Desmopressin,NDA-3: New strength,FERRING PHARMACEUTICALS PRIVATE LIMITED,22/01/2019,SIN15615P
"INFLUVAC TETRA, SUSPENSION FOR INJECTIONIN PREFILLED SYRINGE 0.5ML",Influenza Virus (NH) A/California/07/2009 X-181 (H1N1); Influenza Virus (NH) A/Texas/50/2012 (H3N2); Influenza Virus (NH) B/Brisbane/60/2008; Influenza Virus (NH) B/Massachusetts/2/2012,NDA-2: New combination,ABBOTT LABORATORIES (SINGAPORE) PTE. LTD.,04/12/2018,SIN15591P
VOLTAREN 12 HOURS EMULGEL 2%,Diclofenac Diethylamine,NDA-2: New strength,GSK Consumer Healthcare Singapore Pte Ltd,14/12/2018,SIN15598P
"ESBRIET FILM COATED TABLET 267MG, 801MG",Pirfenidone,"NDA-2, 3: New dosage form, new strength",ROCHE SINGAPORE PTE. LTD.,18/12/2018,"SIN15600P, SIN15601P"
MAVIRET FILM-COATED TABLET 100MG/40MG,Glecaprevir + Pibrentasvir,NDA-1: New chemical,ABBVIE PTE. LTD.,26/12/2018,SIN15603P
ICLUSIG TABLET 15 MG AND 45 MG,Ponatinib HCl,NDA-1: New chemical entity,STEWARD CROSS PTE LTD,19/11/2018,"SIN15581P, SIN15582P"
MIFEGYNE TABLETS 200MG,Mifepristone,NDA-1: New chemical entity,UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED,23/11/2018,SIN15583P
KOVALTRY POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 250IU/VIAL AND 500IU/VIAL,"Antihemophilic factor (Recombinant)250 IU, Antihemophilic factor (Recombinant)500 IU,","NDA-2,3 : New manufacturing process, new strength",BAYER (SOUTH EAST ASIA) PTE LTD,30 Nov 2018,"SIN15587P, SIN15586P"
PRIVIGEN SOLUTION FOR INFUSION 100g/L,Human Immunoglobulin,NDA-2 New formulation,CSL BEHRING PTE LTD,7 Nov 2018,SIN15574P
DIFFLAM PLUS ANAESTHETIC SORE THROAT LOZENGES (SUGAR FREE) MENTHOL AND EUCALYPTUS FLAVOURDIFFLAM PLUS ANAESTHETIC SORE THROAT LOZENGES (SUGAR FREE) HONEY LEMON FLAVOUR,"Benzydamine Hydrochloride + Lignocaine Hydrochloride + 2,4 Dichlorobenzyl Alcohol",NDA-2: New formulation,Inova Pharmaceuticals (Singapore) Pte. Limited,29 Nov 2018,"SIN15584P, SIN15585P"
HEPA-MERZ 5G/10ML Infusion CONCENTRATE,L-ornithine-L-aspartate,NDA-1: New chemical entity,MERZ ASIA PACIFIC PTE. LTD.,09 Nov 2018,SIN15578P
"HEMLIBRA (EMCIZUMAB) SOLUTION FOR INJECTION 150MG/ML, 30MG/ML",Emicizumab,"NDA-1/3: New chemical entity, New strength",ROCHE SINGAPORE PTE LTD,09 Nov 2018,"SIN15576P, SIN15577P"
VIACORAM START TABLET 3.5MG/ 2.5MGVIACORAM TABLET 7MG/ 5MG & 14MG/ 10MG,Amlodipine and Perindopril Arginine,"NDA-2: New dosage form, indication, dosing regimenNDA-3: New strength",SERVIER (S) PTE LTD,01/10/2018,"SIN15555P, SIN15556P, SIN15557P"
TARGIN PROLONGED RELEASE TABLETS 60MG/30MG AND 80MG/40MG,Oxycodone hydrochloride / Naloxone hydrochloride dihydrate,NDA-3: New strength,MUNDIPHARMA PHARMACEUTICALS PTE. LTD.,02/10/2018,"SIN15560P, SIN15561P"
SENSHIO FILM-COATED TABLET 60MG,Ospemifene,NDA-1: New chemical entity,SHIONOGI SINGAPORE PTE. LTD.,26/10/2018,SIN15568P
IMFINZI CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/ML,Durvalumab,NDA-1: New biological entity,ASTRAZENECA SINGAPORE PTE LTD,29/10/2018,SIN15569P
"REKOVELLE SOLUTION FOR INJECTION 12MCG/0.36ML, 36MCG/1.08ML AND 72MCG/2.16ML",Follitropin Delta,NDA-1: New chemical entityNDA-3: New strength,FERRING PHRAMACEUTICALS PRIVATE LIMITED,11/09/2018,"SIN15537P,SIN15538P,SIN15539P"
"SOLIQUA SOLUTION FOR INJECTION IN A PRE-FILLED PEN 100UNIT/ML + 50 MCG/ML, 100 UNITS/ML + 33 MCG/ML","Lixisenatide, Insulin Glargine",NDA-2: New combinationNDA-3: New strength,SANOFI-AVENTIS SINGAPORE PTE LTD,20/09/2018,"SIN15540P, SIN15542P"
AIMOVIG SOLUTION FOR INJECTION IN PRE-FILLED PEN/PRE-FILLED SYRINGE 70MG/ML,Erenumab,NDA-1 and NDA-2: New biological entity,NOVARTIS (SINGAPORE)PTE LTD,21/09/2018,SIN15543P and SIN15545P
TIVICAY FILM-COATED TABLET 10MG AND 25MG,Dolutegravir Sodium,NDA-2/3: New dosage form and new patient population,GLAXOSMITHKLINE PTE LTD,24/08/2018,SIN15532P/ SIN15533P
PARIET TABLET 5MG,Rabeprazole,NDA-2: New strength / indication / dosing regimen,EISAI (SINGAPORE) PTE LTD,23 Aug 2018,SIN15531P
REGIOCIT SOLUTION FOR HAEMOFILTRATION,"Sodium chloride, sodium citrate",NDA-2: New combination,BAXTER HEALTHCARE (ASIA) PTE LTD,19 Jul 2018,SIN15513P
BIPHOZYL SOLUTION FOR HAEMODIALYSIS / HAEMOFILTRATION,Disodium Phosphate DihydratePotassium ChlorideSodium ChlorideSodium Hydrogen CarbonateMagnesium Chloride Hexahydrate,NDA-2: New combination,BAXTER HEALTHCARE (ASIA) PTE LTD,20 Jul 2018,SIN15514P
LEVEMIR PENFILL 100IU/ML,Insulin detemir,NDA-2: New dosage form,NOVO NORDISK PHARMA,20 Jul 2018,SIN15515P
RYDAPT SOFT CAPSULE 25MG,Midostaurin,NDA-1: New chemical entity,NOVARTIS (SINGAPORE) PTE LTD,30 Jul 2018,SIN15518P
HIZENTRA SOLUTION FOR SUBCUTANEOUS INJECTION 200G/L,Human Immunoglobulin,NDA-2: New Indication,CSL BEHRING PTD LTD,5 Jun 2018,SIN15499P
TALTZ SOLUTION FOR INJECTION IN PRE-FILLED PEN80 MG/ML,Ixekizumab,NDA-1: New biological entity,ELI LILLY (SINGAPORE) PTE LTD,6 Jun 2018,SIN15501P
BiCNU (CARMUSTINE FOR INJECTION USP 100MG) & DEHYDRATED ALCOHOL INJECTION USP AS A COMBIPACK,Carmustine,"NDA-2: New dosage form, strength, indication, dosing regimen",ADVAGEN PTE LTD,7 Jun 2018,SIN15502P
OLUMIANT FILM-COATED TABLET 2 AND 4MG,Baricitinib,"NDA-1: New chemical entity, NDA-3: New strength",ELI LILLY (SINGAPORE) PTE LTD,18 Jun 2018,SIN15504P and SIN15505P
TREMFYA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 100MG/ML,Guselkumab,NDA-1: New biological entity,JOHNSON & JOHNSON PTE LTD,21 Jun 2018,SIN15508P
BELKYRA INJECTION 10MG/ML,Deoxycholic acid,NDA-1: New chemical entity,ALLERGAN SINGAPORE PTE LTD,21 Jun 2018,SIN15509P
VAXIGRIPTETRA SUSPENSION FOR INJECTION IN PREFILLED SYRINGE,Influenza Virus (NH) A/California/07/2009 X-179A (H1N1); Influenza Virus (NH) A/Texas/50/2012 (H3N2);Influenza Virus (NH) B/Brisbane/60/2008;Influenza Virus (NH) B/Massachusetts/2/2012,NDA-2: New combination,SANOFI-AVENTIS SINGAPORE PTE. LTD.,4 May 2018,SIN15477P
ADACEL-POLIO SUSPENSION FOR INJECTION IN PREFILLED SYRINGE,(Acellular pertussis) filamentous haemagglutinin adsorbed (FHA)(Acelluar pertussis) fimbriae type 2 and 3 adsorbed (FIM)(Acellular pertussis) pertatctin adsorbed (PRN)(Acellular pertussis) pertussis toxoid adsorbed (PT)Diphtheria toxoid adsorbedInactivated poliomyelitis vaccine (IPV) type 1 mahoneyInactivated poliomyelitis vaccine (IPV) type 2 (MEF-1)Inactivated poliomyelitis vaccine (IPV) type 3 (Saukett)Tetanus toxoid adsorbed,NDA-2: New combination,SANOFI-AVENTIS SINGAPORE PTE LTD,4 May 2018,SIN15479P
NOVOMIX 30 PENFILL 100U/ML,Insulin Aspart,NDA-2: New dosage form,NOVO NORDISK PHARMA (SINGAPORE) PTE LTD,9 May 2018,SIN15480P
LONSUF FILM-COATED TABLET 15 MG/6.14 MG AND 20 MG/8.19 MG,Tipiracil hydrochloride / trifluridine,NDA-1: New chemical entityNDA-3: New strength,TAIHO PHARMA SINGAPORE PTE. LTD.,24 May 2018,SIN15491P and SIN15494P
EPIDUO FORTE GEL 0.3%/ 2.5%,Adapalene/ Benzoyl peroxide,NDA-2: New strength,GALDERMA SINGAPORE PRIVATE LIMITED,3 Apr 2018,SIN15460P
NOCDURNA ORAL LYOPHILISATE 25 MCG AND 50 MCG,Desmopressin,NDA-2: New indication and NDA-3: New strength,FERRING PHARMACEUTICALS PRIVATE LIMITED,3 Apr 2018,SIN15461P and SIN15462P
SODIUM IODIDE NA131I POLATOM CAPSULE,Sodium iodide Na131I,NDA-2: New indication/ dosing regimen,QUANTUM TECHNOLOGIES GLOBAL PTE. LTD.,23 Apr 2018,SIN15467P
NUTRIFLEX®OMEGA PLUS EMULSION FOR INFUSION,"Alanine, Arginine, Aspartic acid, Calcium chloride dihydrate, Glucose monohydrate, Glutamic acid, Glycine, Histidine hydrochloride monohydrate, Isoleucine, Leucine, Lysine hydrochloride, Magnesium acetate tetrahydrate, Methionine, Omega-3-acid triglycerides, Phenylalanine, Potassium acetate, Proline, Serine, Sodium acetate trihydrate, Sodium chloride, Sodium dihydrogen phosphate dihydrate, Sodium hydroxide, Refined soya-bean oil, Threonine, Medium chain triglycerides, Tryptophan, Valine and Zinc acetate dihydrate",NDA-2: New combination,B. BRAUN SINGAPORE PTE. LTD.,23 Apr 2018,SIN15468P
NUTRIFLEX®OMEGA SPECIAL EMULSION FOR INFUSION,"Alanine, Arginine, Aspartic acid, Calcium chloride dihydrate, Glucose monohydrate, Glutamic acid, Glycine, Histidine hydrochloride monohydrate, Isoleucine, Leucine, Lysine hydrochloride, Magnesium acetate tetrahydrate, Methionine, Omega-3-acid triglycerides, Phenylalanine, Potassium acetate, Proline, Serine, Sodium acetate trihydrate, Sodium chloride, Sodium dihydrogen phosphate dihydrate, Sodium hydroxide, Refined soya-bean oil, Threonine, Medium chain triglycerides, Tryptophan, Valine and Zinc acetate dihydrate",NDA-2: New combination,B. BRAUN SINGAPORE PTE. LTD.,23 Apr 2018,SIN15469P
VIZAMYL SOLUTION FOR INJECTION 150 MBQ/ ML,Flutemetamol[18F],NDA-1: New chemical entity,GE HEALTHCARE PTE. LTD.,6 Mar 2018,SIN15441P
VOCINTI FILM-COATED TABLET 10 MG AND 20 MG,Vonoprazan,NDA-1: New chemical entity and NDA-3: New strength,TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.,8 Mar 2018,SIN15444P and SIN15445P
"PARSABIV SOLUTION FOR INJECTION 2.5 MG/ 0.5 ML, 5 MG/ ML AND 10 MG/ 2 ML",Etelcalcetide,NDA-1: New chemical entity and NDA-3: New strength,AMGEN SINGAPORE MANUFACTURING PTE. LTD.,14 Mar 2018,"SIN15450P, SIN15451P and SIN15452P"
CANESPRO ONCE DAILY CREAM 1%,Bifonazole,NDA-1: New chemical entity,BAYER (SOUTH EAST ASIA) PTE. LTD.,1 Feb 2018,SIN15415P
TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 1200 MG/ 20 ML,Atezolizumab,NDA-1: New biological entity,ROCHE SINGAPORE PTE. LTD.,9 Feb 2018,SIN15425P
"TRIVERAM FILM-COATED TABLET 10 MG/ 5 MG/ 5 MG, 20 MG/ 5 MG/ 5 MG, 20 MG/ 10 MG/ 5 MG, 20 MG/ 10 MG/ 10 MG AND 40 MG/ 10 MG/ 10 MG",Atorvastatin/ Perindopril/ Amlodipine,NDA-2: New combination and NDA-3: New strength,SERVIER (S) PTE. LTD.,12 Feb 2018,"SIN15426P, SIN15427P, SIN15428P, SIN15429P and SIN15430P"
VARITHENA POLIDOCANOL INJECTION FOAM 10 MG/ ML,Polidocanol,NDA-2: New dosage form,TRANSMEDIC PTE. LTD.,15 Feb 2018,SIN15433P
COSOPT-S OPHTHALMIC SOLUTION,Dorzolamide and Timolol,NDA-2: New formulation,SANTEN PHARMACEUTICAL ASIA PTE. LTD.,26 Feb 2018,SIN15435P
STELARA CONCENTRATE FOR SOLUTION FOR INFUSION 130 MG/ 26 ML,Ustekinumab,NDA-2: New indication,JOHNSON & JOHNSON PTE. LTD.,28 Feb 2018,SIN15438P
ZEPATIER FILM-COATED TABLET 50 MG/ 100 MG,Elbasvir/ Grazoprevir,NDA-1: New chemical entity,MSD PHARMA (SINGAPORE) PTE. LTD.,11 Jan 2018,SIN15404P
VELETRI POWDER FOR SOLUTION FOR INFUSION 0.5 MG/ VIAL AND 1.5 MG/ VIAL,Epoprostenol,NDA-2: New indication and NDA-3: New strength,DKSH SINGAPORE PTE. LTD.,11 Jan 2018,SIN15405P and SIN15406P
KISQALI FILM-COATED TABLET 200 MG,Ribociclib,NDA-1: New chemical entity,NOVARTIS (SINGAPORE) PTE. LTD.,22 Jan 2018,SIN15407P
KYPROLIS POWDER FOR SOLUTION FOR INFUSION 30 MG/ VIAL,Carfilzomib,NDA-3: New strength,AMGEN SINGAPORE MANUFACTURING PTE. LTD.,29 Jan 2018,SIN15414P
VEMLIDY FILM COATED TABLET 25 MG,Tenofovir Alafenamide Fumarate,NDA-2: New indication,GILEAD SCIENCES SINGAPORE PTE. LTD.,11 Dec 2017,SIN15392P
SKUDEXA FILM-COATED TABLET 75 MG/ 25 MG,Tramadol Hydrochloride/ Dexketoprofen,NDA-2: New combination,A. MENARINI SINGAPORE PTE. LTD.,13 Dec 2017,SIN15394P
NUCALA POWDER FOR SOLUTION FOR INJECTION 100 MG,Mepolizumab,NDA-1: New biological entity,GLAXOSMITHKLINE PTE. LTD.,14 Dec 2017,SIN15396P
ONIVYDE (IRINOTECAN LIPOSOME) INJECTION 43 MG/ 10 ML,Irinotecan,NDA-2: New formulation,SHIRE SINGAPORE PTE. LTD.,28 Dec 2017,SIN15397P
COSYREL FILM-COATED TABLET 5 MG/ 5 MGCOSYREL FILM-COATED TABLET 5 MG/ 10 MGCOSYREL FILM-COATED TABLET 10 MG/ 5 MGCOSYREL FILM-COATED TABLET 10 MG/ 10 MG,Bisoprolol/ Perindopril,NDA-2: New combination and NDA-3: New strength,SERVIER (S) PTE. LTD.,28 Dec 2017,"SIN15398P, SIN15399P, SIN15400P and SIN1401P"
NUVANIV SOFT CAPSULE 0.5 MG,Dutasteride,NDA-2: New indication,GLAXOSMITHKLINE PTE. LTD.,16 Nov 2017,SIN15364P
STREPSILS MAX PRO DIRECT SPRAY 8.75 MG PER DOSE,Flurbiprofen,NDA-2: New dosage form,RECKITT BENCKISER (SINGAPORE) PTE. LTD.,29 Nov 2017,SIN15370P
GELASPAN SOLUTION FOR INFUSION,"Calcium Chloride Dihydrate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Acetate Trihydrate, Sodium Chloride, Succinylated Gelatine",NDA-2: New formulation,B. BRAUN SINGAPORE PTE. LTD.,4 Oct 2017,SIN15336P
SAXENDA SOLUTION FOR INJECTION IN PRE-FILLED PEN6 MG/ ML,Liraglutide,NDA-2: New indication/ dosing regimen,NOVO NORDISK PHARMA (SINGAPORE) PTE. LTD.,9 Oct 2017,SIN15338P
FLUIMUCIL A 600 EFFERVESCENT TABLET 600 MG (OTC PACK)FLUIMUCIL GRANULES 100 MG/ SACHET (OTC PACK),Acetylcysteine,NDA-2: New indication,UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED,13 Oct 2017,SIN15339P and SIN15340P
BETADINE VAGINAL GEL 10% W/ W,Povidone Iodine,NDA-2: New dosage form,MUNDIPHARMA PHARMACEUTICALS PTE. LTD.,13 Oct 2017,SIN15344P
"IMPLICOR FILM-COATED TABLET 25 MG/ 5 MG,25 MG/ 7.5 MG, 50 MG/ 5 MG AND 50 MG/ 7.5 MG",Metoprolol Tartrate/ Ivabradine,NDA-2: New combination and NDA-3: New strength,SERVIER (S) PTE. LTD.,19 Oct 2017,"SIN15347P, SIN15348P, SIN15349P and SIN15350P"
EPCLUSA TABLET 400 MG/ 100 MG,Sofosbuvir/ Velpatasvir,NDA-1: New chemical entity,GILEAD SCIENCES SINGAPORE PTE. LTD.,19 Oct 2017,SIN15351P
NAUSICALM TABLET 50 MG (PHARMACY ONLY),Cyclizine Hydrochloride,NDA-2: New indication,AFT PHARMACEUTICALS SINGAPORE PTE. LTD.,23 Oct 2017,SIN15353P
DATSCAN SOLUTION FOR INJECTION 74 MBQ/ ML,Ioflupane [123I],NDA-1: New chemical entity,GE HEALTHCARE PTE. LTD.,4 Sep 2017,SIN15325P
AMITIZA CAPSULE 8 MCG AND 24 MCG,Lubiprostone,NDA-1: New chemical entity and NDA-3: New strength,TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.,13 Sep 2017,SIN15329P and SIN15330P
FOSTER NEXTHALER INHALATION POWDER 100 MCG/ 6 MCG PER DOSE,Beclometasone dipropionate anhydrous/ Formoterol fumarate dihydrate,NDA-2: New dosage form,ORIENT EUROPHARMA PTE. LTD.,19 Sep 2017,SIN15332P
CORTIMENT MMX PROLONGED RELEASE TABLETS 9 MG,Budesonide,NDA-2: New dosage form,FERRING PHARMACEUTICALS PRIVATE LIMITED,4 Aug 2017,SIN15311P
BETADINE SORE THROAT SPRAY 0.45% W/V,Povidone-Iodine,NDA-2: New dosage form,MUNDIPHARMA PHARMACEUTICALS PTE. LTD.,7 Aug 2017,SIN15313P
ZERBAXA POWDER FOR SOLUTION FOR INJECTION 1 G/ 0.5 G,Ceftolozane and Tazobactam,NDA-1: New chemical entity,MSD PHARMA (SINGAPORE) PTE. LTD.,14 Aug 2017,SIN15317P
DESCOVY FILM COATED TABLET 200 MG/10 MG AND 200 MG/ 25 MG,Emtricitabine/ Tenofovir Alafenamide,NDA-2: New combination and NDA-3: New strength,GILEAD SCIENCES SINGAPORE PTE. LTD.,21 Aug 2017,SIN15321P and SIN15322P
"UPTRAVI FILM-COATED TABLETS 200 MCG, 400 MCG, 600 MCG, 800 MCG, 1000 MCG, 1200 MCG, 1400 MCG AND 1600 MCG",Selexipag,NDA-1: New chemical entity and NDA-3: New strength,DKSH SINGAPORE PTE. LTD.,6 July 2017,"SIN15283P, SIN15824P, SIN15285P, SIN15286P, SIN15287P, SIN15288P, SIN15289P and SIN15290P"
AZILECT TABLET 1 MG,Rasagiline,NDA-1: New chemical entity,LUNDBECK SINGAPORE PTE. LTD.,7 July 2017,SIN15291P
PORTRAZZA CONCENTRATE FOR SOLUTION FOR INFUSION 800 MG/ 50 ML,Necitumumab,NDA-1: New biological entity,ELI LILLY (SINGAPORE) PTE. LTD.,7 July 2017,SIN15292P
ALOXI SOFT CAPSULES 500 MCG,Palonosetron,NDA-2: New dosage form,MUNDIPHARMA PHARMACEUTICALS PTE. LTD.,7 July 2017,SIN15293P
BRILINTA TABLET 60 MG,Ticagrelor,NDA-2: New strength/ indication,ASTRAZENECA SINGAPORE PTE. LTD.,07/07/2017,SIN15294P
DICLECTIN DELAYED RELEASE TABLETS 10 MG/ 10 MG,Doxylamine Succinate/ Pyridoxine Hydrochloride,NDA-1: New chemical entity,UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED,20 July 2017,SIN15301P
D-CURE ORAL SOLUTION 25000 IU,Cholecalciferol,NDA-2: New dosage form,HYPHENS PHARMA PTE. LTD.,5 Jun 2017,SIN15254P
DYMISTA NASAL SPRAY,Azelastine Hydrochloride and Fluticasone Propionate,NDA-2: New combination,PHARMLINE MARKETING PTE. LTD.,5 Jun 2017,SIN15255P
SYNAZE NASAL SPRAY,Azelastine Hydrochloride and Fluticasone Propionate,NDA-2: New combination,PHARMLINE MARKETING PTE. LTD.,5 Jun 2017,SIN15256P
"VENCLEXTA FILM-COATED TABLET 10 MG, 50 MG AND 100 MG",Venetoclax,NDA-1: New chemical entity and NDA-3: New strength,ABBVIE PTE. LTD.,8 Jun 2017,"SIN15265P, SIN15266P and SIN15267P"
BUFFERED BINOSTO EFFERVESCENT TABLET 70 MG,Alendronic Acid,NDA-2: New dosage form,ZUELLIG PHARMA PTE. LTD.,8 Jun 2017,SIN15268P
GLYXAMBI FILM-COATED TABLETS 10 MG/ 5 MGAND 25 MG/ 5 MG,Empagliflozin/ Linagliptin,NDA-2: New combination and NDA-3: New strength,BOEHRINGER INGELHEIM SINGAPORE PTE. LTD.,16 Jun 2017,SIN15272P and SIN15273P
DUAKLIR GENUAIR INHALATION POWDER 340/ 12 MCG/ DOSE,Aclidinium Bromide/ Formoterol Fumarate Dihydrate,NDA-2: New combination,ASTRAZENECA SINGAPORE PTE. LTD.,3 May2017,SIN15231P
DYSPORT FOR INJECTION 300U/VIAL,Clostridium Botulinum Type A Toxin-Haemagglutinin Complex,NDA-3: New strength,A. MENARINI SINGAPORE PTE. LTD.,16 May2017,SIN15238P
"ADJUPANRIX PANDEMIC INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED, AS03 ADJUVANTED)","Split Influenza Virus, Inactivated, containing antigen eqv A/Vietnam/1194/2004 (H5N1)",NDA-2: New indication/ dosing regimen,GLAXOSMITHKLINE PTE. LTD.,17 May 2017,SIN15239P
AVONEX SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 30 MCG/ 0.5 MLAVONEX SOLUTION FOR INJECTION IN PRE-FILLED PEN 30 MCG/ 0.5 ML,Interferon Beta-1a,NDA-2: New dosage form,UCB TRADING (SG) PTE. LTD.,18May 2017,SIN15240P and SIN15241P
PAZEO OPTHALMIC SOLUTION 0.7%,Olopatadine,NDA-2: new strength,ALCON PTE LTD,22 May 2017,SIN15242P
GLIOLAN POWDER FOR ORAL SOLUTION 30MG/ML,Aminolevulinic acid,NDA-1: New chemical entity,LINK HEALTHCARE SINGAPORE PTE LTD,26 May2017,SIN15244P
HUMIRA SOLUTION FOR INJECTION 40MG/0.4ML (SYRINGE AND PEN),Adalimumab,NDA-2: New strength/formulation,ABBVIE PTE LTD,26 May2017,SIN15248P
TRAVATAN C EYE DROP SOLUTION 30 MCG/ ML,Travoprost,NDA-2: New strength,ALCON PTE. LTD.,10 Apr 2017,SIN15206P
KEFENTECH AIR 30 MG/ SHEET,Ketoprofen,NDA-2: New indication,PHARMAFORTE SINGAPORE PTE. LTD.,18 Apr 2017,SIN15212P
"JADENU FILM COATED TABLET 90 MG, 180 MG AND 360 MG",Deferasirox,NDA-2: New dosage form and NDA-3: New strength,NOVARTIS (SINGAPORE) PTE. LTD.,18 Apr 2017,"SIN15213P, SIN15214P and SIN15215P"
"IKERVIS EYE DROPS, EMULSION 1 MG/ ML",Ciclosporin,NDA-2: New dosage form,SANTEN PHARMACEUTICAL ASIA PTE. LTD.,20 Apr 2017,SIN15216P
COTELLIC FILM-COATED TABLET 20 MG,Cobimetinib,NDA-1: New chemical entity,ROCHE SINGAPORE PTE. LTD.,21 Apr 2017,SIN15219P
KANARB TABLET 60 MG AND 120 MG,Fimasartan Potassium,NDA-1: New chemical entity and NDA-3: New strength,ZUELLIG PHARMA PTE. LTD.,24 Apr 2017,SIN15221P and SIN15222P
REPATHA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 140 MG/ MLREPATHA SOLUTION FOR INJECTION IN PRE-FILLED AUTOINJECTOR 140 MG/ ML,Evolocumab,NDA-1: New biological entity and NDA-2: New dosage form,AMGEN SINGAPORE MANUFACTURING PTE. LTD.,24 Apr 2017,SIN15223P and SIN15224P
ALECENSA HARD CAPSULE 150 MG,Alectinib,NDA-1: New chemical entity,ROCHE SINGAPORE PTE. LTD.,24 Apr 2017,SIN15220P
PRALUENT SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE AND PEN 75 MG/ MLPRALUENT SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE AND PEN 150 MG/ ML,Alirocumab,NDA-1: New biological entity and NDA-3: New strength,SANOFI-AVENTIS SINGAPORE PTE. LTD.,27 Apr 2017,SIN15228P and SIN15229P
"INVEGA TRINZA PROLONGED RELEASE SUSPENSION FOR IM INJECTION 175 MG/ 0.875 ML, 263 MG/ 1.315 ML, 350 MG/ 1.75 ML AND 525 MG/ 2.625 ML",Paliperidone,NDA-2: New strength/ indication/ dosing regimen NDA-3: New strength,JOHNSON & JOHNSON PTE. LTD.,6 Mar 2017,"SIN15186P, SIN15187P, SIN15188P and SIN15189P"
EKLIRA GENUAIR INHALATION POWDER 322 MICROGRAM/ DOSE,Aclidinium,NDA-1: New chemical entity,ASTRAZENECA SINGAPORE PTE. LTD.,7 Mar 2017,SIN15190P
ABILIFY MAINTENA POWDER AND SOLVENT FOR PROLONGED RELEASE SUSPENSION FOR INJECTION 400 MG,Aripiprazole,NDA-2: New dosage form/ indication,LUNDBECK SINGAPORE PTE. LTD.,14 Mar 2017,SIN15192P
NAUSICALM TABLET 50 MG,Cyclizine Hydrochloride,NDA-1: New chemical entity,AFT PHARMACEUTICALS SINGAPORE PTE. LTD.,20 Mar 2017,SIN15193P
SOOLANTRA CREAM 10 MG/ G,Ivermectin,NDA-2: New dosage form/ indication/ dosing regimen,GALDERMA SINGAPORE PTE. LTD.,23 Mar 2017,SIN15197P
NUROMOL FILM COATED TABLET 200 MG/ 500 MG,Ibuprofen/ Paracetamol,NDA-2: New combination,RENCKITT BENCKISER (SINGAPORE) PTE. LTD.,28 Mar 2017,SIN15200P
"OTEZLA TABLET STARTER PACK,OTEZLA TABLET 30 MG",Apremilast,NDA-1: New chemical entity and NDA-3: New strength,CELGENE PTE. LTD.,29 Mar 2017,SIN15202P and SIN15203P
"SIGNIFOR LAR POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION 20 MG, 40MG AND 60 MG",Pasireotide,NDA-2: New formulation/ strength/ indication and NDA-3: New strength,NOVARTIS (SINGAPORE) PTE. LTD.,2 Feb 2017,"SIN15168P, SIN15169P and SIN15170P"
PERIOCLINE PERIODONTAL OINTMENT 2% W/W,Minocycline,NDA-2: New dosage form/ strength/ indication/ dosing regimen,SUNSTAR SINGAPORE PTE.LTD.,3 Feb 2017,SIN15172P
DURATOCIN RTS SOLUTION FOR INJECTION 100 MCG/ ML,Carbetocin,NDA-2: New formulation,FERRING PHARMACEUTICALS PTE. LTD.,8 Feb 2017,SIN15173P
MEKINIST FILM-COATED TABLETS 0.5 MG AND 2 MG,Trametinib,NDA-1: New chemical entity and NDA-3: New strength,NOVARTIS (SINGAPORE) PTE. LTD.,27 Feb 2017,SIN15181P and SIN15182P
KYPROLIS POWDER FOR SOLUTION FOR INFUSION 60 MG/ VIAL,Carfilzomib,NDA-1: New chemical entity,ADOR CONSULTING PTE. LTD.,28 Feb 2017,SIN15184P
CLOBEX SPRAY 0.05% W/W,Clobetasol Propionate,NDA-2: New dosage form,GALDERMA SINGAPORE PTE. LTD.,28 Feb 2017,SIN15185P
INOVELON FILM-COATED TABLET 200 MG,Rufinamide,NDA-1: New chemical entity,EISAI (SINGAPORE) PTE. LTD.,5 Jan 2017,SIN15146P
"ABSTRAL SUBLINGUAL TABLET 100 MCG, 200 MCG, 300 MCG, 400 MCG, 600 MCG AND 800 MCG",Fentanyl,NDA-2: New dosage form and NDA-3: New strength,A. MENARINI SINGAPORE PTE. LTD.,6 Jan 2017,"SIN15147P, SIN15148P, SIN15149P, SIN15150P, SIN15151P and SIN15152P"
"ALBUNORM SOLUTION FOR INFUSION 5%, 20% AND 25%",Human Albumin,NDA-2: New formulation and NDA-3: New strength,WELLCHEM PHARMACEUTICALS PTE. LTD.,19 Jan 2017,"SIN15159P, SIN15160P and SIN15161P"
GENVOYA FILM COATED TABLET 150 MG/ 150 MG/ 200 MG/ 10 MG,Elvitegravir/ Cobicistat/ Emtricitabine/ Tenofovir Alafenamide Fumarate,NDA-1: New chemical entity,GILEAD SCIENCES SINGAPORE PTE. LTD.,20 Jan 2017,SIN15165P
"NINLARO CAPSULE 2.3 MG, 3 MG AND 4 MG",Ixazomib,NDA-1: New chemical entity and NDA-3: New strength,TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.,20 Jan 2017,"SIN15162P, SIN15163P and SIN15164P"
ESBRIET HARD CAPSULE 267 MG,Pirfenidone,NDA-1: New chemical entity,ROCHE SINGAPORE PTE. LTD.,1 Dec 2016,SIN15124P
PENTASA RECTAL SUSPENSION 1 G,Mesalazine,NDA-2: New dosage form,FERRING PHARMACEUTICALS PTE. LTD.,14 Dec 2016,SIN15137P
TOUJEO SOLOSTAR 300 UNITS/ ML SOLUTION FOR INJECTION IN A PRE-FILLED PEN,Insulin Glargine,NDA-2: New strength,SANOFI-AVENTIS SINGAPORE PTE. LTD.,14 Dec 2016,SIN15138P
TAGRISSO TABLET 40 MG AND 80 MG,Osimertinib,NDA-1: New chemical entity and NDA-3: New strength,ASTRAZENECA SINGAPORE PTE. LTD.,15 Dec 2016,SIN15139P and SIN15140P
GARDASIL 9 SUSPENSION FOR INJECTION,Human Papillomavirus Type 11 L1 ProteinHuman Papillomavirus Type 16 L1 ProteinHuman Papillomavirus Type 18 L1 ProteinHuman Papillomavirus Type 31 L1 ProteinHuman Papillomavirus Type 33 L1 ProteinHuman Papillomavirus Type 45 L1 ProteinHuman Papillomavirus Type 52 L1 ProteinHuman Papillomavirus Type 58 L1 ProteinHuman Papillomavirus Type 6 L1 Protein,NDA-1: New biological entity,MSD PHARMA (SINGAPORE) PTE. LTD.,16 Dec 2016,SIN15141P
FLUIMUCIL GRANULES 600 MG/ SACHET,Acetylcysteine,NDA-2: New dosage form,UNITED ITALIAN TRADING CORPORATION (PTE) LTD.,29 Dec 2016,SIN15144P
SYNAGIS SOLUTION FOR INJECTION 100 MG/ ML,Palivizumab,NDA-2: New dosage form,ABBVIE PTE. LTD.,7 Nov 2016,SIN15112P
NIVOLUMAB BMS CONCENTRATE FOR SOLUTION FOR INFUSION 10 MG/ ML,Nivolumab,NDA-2: New indication,BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.,9 Nov 2016,SIN15117P
"ATOZET TABLET 10 MG/ 10 MG, 10 MG/ 20 MG, 10 MG/ 40 MG AND 10 MG/ 80 MG",Ezetimibe/ Atorvastatin,NDA-2: New combination and NDA-3: New strength,MSD PHARMA (SINGAPORE) PTE. LTD.,9 Nov 2016,"SIN15113P, SIN15114P, SIN15115P and SIN15116P"
BYDUREON POWDER AND SOLVENT FOR PROLONGED- RELEASE SUSPENSION FOR INJECTION IN PRE-FILLED PEN 2 MG,Exenatide,NDA-2: New dosage form/ dosing regimen,ASTRAZENECA SINGAPORE PTE. LTD.,10 Oct 2016,SIN15095P
"DENGVAXIA, POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION","CYD Dengue Virus Serotypes 1, 2, 3 and 4",NDA-1: New biological entity,SANOFI-AVENTIS SINGAPORE PTE. LTD.,11 Oct 2016,SIN15096P
"DENGVAXIA MD, POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION","CYD Dengue Virus Serotypes 1, 2, 3 and 4",NDA-2: New formulation (multi-dose),SANOFI-AVENTIS SINGAPORE PTE. LTD.,11 Oct 2016,SIN15097P
NEUROBION TABLET (OTC),"Cyanocobalamin, Pyridoxine Hydrochloride and Thiamine Disulphide",NDA-2: New indication,MERCK PTE. LTD.,13 Oct 2016,SIN15098P
TRIUMEQ FILM COATED TABLET 50 MG/ 600 MG/ 300 MG,Dolutegravir/ Abacavir/ Lamivudine,NDA-2: New combination,GLAXOSMITHKLINE PTE. LTD.,14 Oct 2016,SIN15100P
BLINCYTO POWDER FOR INFUSION 35 MCG/ VIAL,Blinatumomab,NDA-1: New biological entity,ADOR CONSULTING PTE. LTD.,18 Oct 2016,SIN15103P
DARZALEX CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ 5 ML AND 400 MG/ 20 ML,Daratumumab,NDA-1: New biological entity and NDA-3: New strength,JOHNSON & JOHNSON PTE. LTD.,26 Oct 2016,"SIN15110P, SIN15111P"
"SIMBRINZA EYE DROPS, SUSPENSION 10 MG/ML + 2 MG/ML","Brinzolamide, Brimonidine Tartrate",NDA-2: New combination,ALCON PTE. LTD.,6 Sep 2016,SIN15085P
LATUDA TABLET 40 MG AND 80 MG,Lurasidone Hydrochloride,NDA-1: New chemical entity and NDA-3: New strength,DKSH SINGAPORE PTE. LTD.,14 Sep 2016,SIN15088P and SIN15089P
VOLIBRIS FILM-COATED TABLET 5 MG AND 10 MG,Ambrisentan,NDA-1: New chemical entity and NDA-3: New strength,GLAXOSMITHKLINE PTE. LTD.,30 Sep 2016,SIN15093P and SIN15094P
TAPCOM-S OPHTHALMIC SOLUTION,"Tafluprost, Timolol",NDA-2: New combination,SANTEN PHARMACEUTICAL ASIA PTE. LTD.,2 Aug 2016,SIN15060P
"JARDIANCE DUO FILM COATED TABLET 5 MG/500 MG, 12.5 MG/500 MG, 12.5 MG/850 MG, 12.5 MG/1000 MG","Empagliflozin, Metformin Hydrochloride",NDA-2: New combination and NDA-3: New strength,BOEHRINGER INGELHEIM SINGAPORE PTE. LTD.,3 Aug 2016,"SIN15061P, SIN15062P, SIN15063P, SIN15064P"
"FARYDAK HARD GELATIN CAPSULE 10 MG, 15 MG, 20 MG",Panobinostat,NDA-1: New chemical entity and NDA-3: New strength,NOVARTIS (SINGAPORE) PTE. LTD.,24 Aug 2016,"SIN15071P, SIN15072P, SIN15073P"
"XIGDUO XR TABLETS 5 MG/500 MG, 10 MG/500 MG, 5 MG/1000 MG, 10 MG/1000 MG","Dapagliflozin, Metformin Hydrochloride",NDA-2: New combination and NDA-3: New strength,ASTRAZENECA SINGAPORE PTE. LTD.,30 Aug 2016,"SIN15077P, SIN15078P, SIN15079P, SIN15080P"
BASAGLAR INJECTION 100 UNITS/MLBASAGLAR KWIKPEN INJECTION 100 UNITS/ML,Insulin Glargine,NDA-2: Biosimilar,ELI LILLY (SINGAPORE) PTE. LTD.,30 Aug 2016,"SIN15081P, SIN15082P"
PRAXBIND SOLUTION FOR INJECTION/INFUSION 50 MG/ML,Idarucizumab,NDA-1: New biological entity,BOEHRINGER INGELHEIM SINGAPORE PTE. LTD.,31 Aug 2016,SIN15083P
NOXAFIL TABLET 100 MG,Posaconazole,NDA-2: New dosage form/ dosing regimen,MSD PHARMA (SINGAPORE) PTE. LTD.,5 Jul 2016,SIN15045P
OLYSIO ORAL CAPSULES 150 MG,Simeprevir,NDA-1: New chemical entity,JOHNSON & JOHNSON PTE. LTD.,15 Jul 2016,SIN15046P
CRAVIT OPHTHALMIC SOLUTION 1.5% W/V,Levofloxacin Hydrate,NDA-2: New strength,SANTEN PHARMACEUTICAL ASIA PTE. LTD.,18 Jul 2016,SIN15047P
"IBRANCE CAPSULE 75MG, 100MG AND 125MG",Palbociclib,NDA-1: New chemical entity and NDA-3: New strength,PFIZER PTE. LTD.,21 Jul 2016,"SIN15048P, SIN15049P, SIN15050P"
OCTOCAINE 100 INJECTION,"Lidocaine Hydrochloride, Epinephrine",NDA-2: New strength,RAYDENT SUPPLIES (S) PTE. LTD.,21 Jul 2016,SIN15051P
TECFIDERA GASTRO-RESISTANT HARD CAPSULES 120MG AND 240MG,Dimethyl Fumarate,NDA-1: New chemical entity and NDA-3: New strength,UCB TRADING (SINGAPORE) PTE. LTD.,26 Jul 2016,"SIN15053P, SIN15054P"
PNEUMOVAX 23 (PREFILLED SYRINGE),Pneumococcal Polysaccharides 23 Most Prevalent Types,NDA-2: New dosage form,MSD PHARMA (SINGAPORE) PTE. LTD.,27 Jul 2016,SIN15055P
LYNPARZA HARD CAPSULE 50MG,Olaparib,NDA-1: New chemical entity,ASTRA ZENECA SINGAPORE PTE LTD,1 Jun 2016,SIN15025P
JAYDESS INTRAUTERINE SYSTEM 13.5MG,Levonorgestrel,NDA-2: New strength,BAYER (SOUTH EAST ASIA) PTE LTD,1 Jun 2016,SIN15024P
MABTHERA SOLUTION FOR SUBCUTANEOUS INJECTION 1400MG,Rituximab,NDA-2: New dosage form/ dosing regimen,ROCHE SINGAPORE PTE LTD,1 Jun 2016,SIN15023P
TETRAXIM VACCINE,"Tetanus Toxoid, Poliovirus (Inactivated) Type 3 (Saukett), Poliovirus (Inactivated) Type 2 (MEF-1), Poliovirus (Inactivated) Type 1 (Mahoney), Pertussis Toxoid, Filamentous Haemagglutinin and Diphtheria Toxoid",NDA-2: New indication,SANOFI-AVENTIS SINGAPORE PTE LTD,6 Jun 2016,SIN15026P
AKYNZEO CAPSULES 300MG/0.5MG,Netupitant and Palonosetron,NDA-1: New chemical entity,MUNDIPHARMA PHARMACEUTICALS PTE LTD,8 Jun 2016,SIN15031P
CYRAMZA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML AND 500MG/50ML,Ramucirumab,NDA-1: New biological entity and NDA-3: New strength,ELI LILY SINGAPORE PTE LTD,21 Jun 2016,SIN15035P and SIN15036P
CONCOR AMLO TABLET 5MG/5MG AND 5MG/10MG,Bisoprolol and Amlodipine,NDA-2: New combination and NDA-3: New strength,MERCK PTE LTD,21 Jun 2016,SIN15033P and SIN15034P
MEZAVANT XL GASTRO-RESISTANT PROLONGED RELEASE TABLET 1200MG,Mesalazine,NDA-2: New dosage form,LF ASIA DISTRIBUTION,3 May 2016,SIN14999P
ENDOMETRIN VAGINAL TABLETS 100MG,"Progesterone, micronized",NDA-2: New dosage form,FERRING PHARMACEUTICALS PRIVATE LIMITED,12 May 2016,SIN15005P
TRIPLIXAM FILM COATED TABLET 2.5 MG / 0.625 MG / 5 MGTRIPLIXAM FILM COATED TABLET 5 MG / 1.25 MG / 5 MGTRIPLIXAM FILM COATED TABLET 5 MG / 1.25 MG / 10 MGTRIPLIXAM FILM COATED TABLET 10 MG / 2.5 MG / 5 MGTRIPLIXAM FILM COATED TABLET 10 MG / 2.5 MG / 10 MG,Perindopril arginine / Indapamide / Amlodipine,NDA-2: New combination,SERVIER (S) PTE LTD,23 May 2016,"SIN15010P, SIN15011P, SIN15012P, SIN15013P, SIN15014P"
ARNUITY ELLIPTA INHALATION POWDER 100 MCG/DOSE AND 200 MCG/DOSE,Fluticasone furoate (micronised),NDA-2: New formulation,GLAXOSMITHKLINE PTE LTD,27 May 2016,"SIN15021P, SIN15022P"
OPDIVO CONCENTRATE FOR SOLUTION FOR INFUSION 10 MG/ML,Nivolumab,NDA-1: New Biological Entity,BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.,4 Apr 2016,SIN14975P
MALTOFER FILM COATED TABLETS 100 MG,Iron (III)-Hydroxide polymaltose complex,NDA-2: New dosage form,VIFOR PHARMA ASIA PACIFIC PTE LTD,6 Apr 2016,SIN14981P
LENVIMA HARD CAPSULE 4 MG AND 10 MG,Lenvatinib mesilate,NDA-1: New chemical entityNDA-3: New strength,EISAI (SINGAPORE) PTE. LTD.,7 Apr 2016,SIN14982P and SIN14983P
BIOFLOR CAPSULE 250MG,Saccharomyces boulardii (lyophilized),NDA-2: New dosage form,UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED,8 Apr 2016,SIN14986P
MISODEL VAGINAL DELIVERY SYSTEM 200 MCG,Misoprostol,NDA-2: New dosage form,FERRING PHARMACEUTICALS PTE. LTD.,19 Apr 2016,SIN14990P
GANFORT PF EYE DROPS,"Bimatoprost, Timolol",NDA-2: New formulation,ALLERGAN SINGAPORE PTE. LTD.,11 Mar 2016,SIN14966P
TRULICITY INJECTION 0.75 MG/0.5 ML AND 1.5 MG/0.5 ML,Dulaglutide,NDA-1: New chemical entityNDA-3: New strength,ELI LILLY (SINGAPORE) PTE LTD,18 Mar 2016,"SIN14967P, SIN14968P"
REMSIMA® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/VIAL,Infliximab,NDA-2: Biosimilar,CELLTRION HEALTHCARE SINGAPORE PRIVATE LIMITED,28 Mar 2016,SIN14972P
FLUQUADRI VACCINE 0.5 ML/PREFILLED SYRINGEFLUQUADRI VACCINE 0.25 ML/PREFILLED SYRINGE,A/California/07/2009 X-179A (H1N1)A/Texas/50/2012 X-223A (H3N2)B/Brisbane/60/2008B/Massachusetts/2/2012,NDA-2: New combination,SANOFI-AVENTIS SINGAPORE PTE. LTD.,4 Feb 2016,"SIN14942P, SIN14941P"
"ENTRESTO FILM COATED TABLET 50MG, 100MG, 200MG",Sacubitril/Valsartan,NDA-1: New chemical entityNDA-3: New strength,NOVARTIS (SINGAPORE) PTE LTD,12 Feb 2016,"SIN14947P, SIN14948P, SIN14949P"
ENTYVIO POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/VIAL,Vedolizumab,NDA-1: New biological entity,TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.,12 Feb 2016,SIN14950P
"ZYDELIG FILM COATED TABLET 100MG, 150MG",Idelalisib,NDA-1: New chemical entityNDA-3: New strength,GILEAD SCIENCES SINGAPORE PTE LTD,16 Feb 2016,"SIN14951P, SIN14952P"
NUROFEN FOR CHILDREN 200MG/5ML SYRUP,Ibuprofen,NDA-3: New strength,RECKITT BENCKISER (SINGAPORE) PTE LTD.,19 Feb 2016,SIN14958P
FEBURIC FILM COATED TABLETS 80 MG,Febuxostat,NDA-1: New chemical entity,ASTELLAS PHARMA SINGAPORE PTE. LTD.,19 Feb 2016,SIN14959P
POLIO SABIN ONE AND THREE (ORAL) VACCINE,"Virus polio type 1, Strain LSc, 2ab, Polio virus type 3, Strain Leon 12a, 1b",NDA-2: New combination,GLAXOSMITHKLINE PTE. LTD.,23 Feb 2016,SIN14960P
"SYMBICORT RAPIHALER SUSPENSION FOR INHALATION 160/4.5, 80/4.5, 80/2.25, 40/2.25 MCG/ACTUATION",Budesonide / Formoterol Fumarate Dihydrate,"NDA-2: New indication, dosing regimenNDA-3: New Strength",ASTRAZENECA SINGAPORE PTE LTD,24 Feb 2016,"SIN14961P, SIN14962P, SIN14963P, SIN14964P"
COMPLERA FILM-COATED TABLET 200MG/25MG/300MG,Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate,NDA-2: New combination,JOHNSON & JOHNSON PTE. LTD.,29 Feb 2016,SIN14965P
LEMTRADA CONCENTRATE FOR SOLUTION FOR INFUSION 12 MG/1.2ML,Alemtuzumab,NDA-2: New strength / indication / dosing regimen,SANOFI-AVENTIS SINGAPORE PTE. LTD.,8 Jan 2016,SIN14919P
HARVONI TABLET 90MG/400 MG,Ledipasvir/Sofosbuvir,NDA-1: New chemical entity,GILEAD SCIENCES SINGAPORE PTE. LTD.,13 Jan 2016,SIN14920P
OFEV SOFT CAPSULES 100MG AND 150MG,Nintedanib,NDA-1: New chemical entityNDA-3: New strength,BOEHRINGER INGELHEIM PTE LTD,14 Jan 2016,"SIN14921P, SIN14922P"
SPIOLTO RESPIMAT INHALATION SOLUTION 2.5MCG/2.5MCG PER ACTUATION,Tiotropium/ Olodaterol,NDA-2: New combination,BOEHRINGER INGELHEIM SINGAPORE PTE. LTD.,20 Jan 2016,SIN14923P
JAKAVI TABLET 10MG,Ruxolitinib Phosphate,NDA-3: New strength,NOVARTIS (SINGAPORE) PTE LTD,25 Jan 2016,SIN14927P
"OSENI FILM COATED TABLET 12.5MG/15MG, 12.5MG/30MG, 25MG/15MG, 25MG/30MG",Alogliptin/Pioglitazone,NDA-2: New combinationNDA-3: New strength,TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.,26 Jan 2016,"SIN14929P, SIN14930P, SIN14931P, SIN14932P"
GAMUNEX-C SOLUTION FOR INFUSION 10%,Human Normal Immunoglobulin,"NDA-2: New indication, route of administration",GRIFOLS ASIA PACIFIC PTE. LTD.,26 Jan 2016,SIN14928P
OCTAPLEX POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 500IU,"Factor II, IX, VII, X, Protein C and Protein S",NDA-1: New biological entity,WELCHEM PHARMACEUTICALS PTE LTD,28 Jan 2016,SIN14933P
